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ABSTRACT  
 
Eric J Sobolewski: The Time Course of Changes in Neuromuscular Function during and 
following Creatine Loading 
(Under the Direction of Eric D. Ryan) 
The purposes of the present study were to determine the effect of Creatine (Cr) supplementation 
on 1) voluntary isometric and isokinetic strength and 2) active and passive range of motion 
(ROM) during loading and the subsequent washout period.  The secondary purpose was to 
address any possible underlying neuromuscular mechanisms that might influence these changes.  
Using a double-blinded, placebo-controlled, matched-paired, randomized design, 40 males were 
assigned to a Cr (n=20, age: 20.3 ± 2.1 yrs,) or a placebo group (Pl; 20.4 ± 2.3 yrs) group. 
Participants supplemented four times daily for five days with 5g Cr + 20g dextrose or 20g 
dextrose.  Testing was conducted prior to supplementation, during the loading phase (days 2, 4 & 
6), and during the washout period (day 20 & 35).  Muscular strength was examined with a 
maximal isometric and isokinetic (30, 90 & 120°·sec
-1
) muscle action of the plantar flexors on a 
calibrated isokinetic dynamometer.  Muscle activation was determined by examining percent 
voluntary activation (%VA) and normalized electromyographic (EMG) amplitudes. Passive 
ROM , common and relative passive stiffness values were determined from a slow passive ROM 
assessment on a dynamometer.  Active ROM was determined as the maximal dorsiflexion 
possible. Total body water, extracellular water, and intracellular water were measured with 
Bioimpedance Spectroscopy.  Panoramic ultrasound imaging was used to address architectural 
changes in muscle cross sectional area, pennation angle, and fascicle length. Resting evoked 
twitch properties were performed to examine Cr-induced changes in Ca²
+
 kinetics.  Magnetic 
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resonance spectroscopy (MRS) was used to evaluate Cr uptake by the muscle in a subset of 
participants (Cr = 4; Pl = 4).  Mass and fluid distribution for the Cr group did not significantly 
(P≥0.11) differ from the Pl group over the course of the study.   There was no significant 
interactions for all strength measures (P≥0.36) or active and passive ROM (P≥0.15), or any of 
the possible underlying mechanism (P>0.05). There were no changes in Cr stores (P>0.05). 
Overall, the results of this study suggest that Cr supplementation alone does not influence 
neuromuscular function or any of the underlying factors that could improve strength or limit 
ROM.   
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CHAPTER I 
INTRODUCTION 
Physiological Role of Creatine 
Creatine (Cr) is one of the most popular ergogenic aids on the market.  Its popularity 
could be contributed to the large number of studies demonstrating its positive influence on high 
intensity exercise performance.
102
  Cr is a naturally occurring organic compound usually 
consumed in the diet as it is found in meat and fish. Cr is also synthesized in the liver and 
pancreas from the amino acids glycine, arginine, and methionine.
109
   The majority of Cr (95%) 
is stored in skeletal muscle, with the remaining 5% found in the heart, brain and testes.  Cr is 
primarily (~60%) found bound to inorganic phosphate in the form of phosphocreatine (PCr) with 
the remaining 40% stored as the free form of Cr.  Cr’s role in metabolism was first discovered by 
Hutlman et al,
49
 who identified Cr and its ability to re-phosphorylate adenosine diphosphate 
(ADP) to adenosine triphosphate (ATP) via the creatine kinase reaction.  It was not until 1992 
when Harris et al
42
 demonstrated Cr supplementation could increase muscle Cr stores both as 
PCr and free form Cr.  Since this ground breaking study, Cr research has further evaluated the 
possible implications of Cr supplementation as an ergogenic aid.  
Dietary supplementation with Cr has been shown to increase PCr stores in muscle, 
increasing the cells ability to re-phosphorylate ATP.
38,63,84
  Previous authors have suggested that 
Cr may have many other positive functions inside the cell which may be influenced by Cr 
supplementation.  For example, Cr along with PCr act as a buffer by shuttling ATP from inside 
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the mitochondria to the cytosol,
74
 and during times of low pH, PCr and ADP buffer hydrogen 
ions (H
+
) by the formation of Cr and ATP.
83
  Cr may also have additional metabolic effects due 
to its potential involvment in regulating glycolysis.
81
 For example, low levels of Cr promote the 
release of oxidative enzymes that in turn increase glycolysis. Cr may also indirectly increase 
protein synthesis.  An increase in Cr concentrations through the breakdown of PCr to Cr during 
muscle contractions has been shown to stimulate protein synthesis.
50
   Swelling of muscle cells 
has also been suggested to increase protein synthesis.
43
  Since Cr has known osmotic properties 
and results in the cells pulling water from the extracellular fluid into the cells causing them to 
swell,
9
 it is likely this may lead indirectly to increases in protein synthesis.  Lastly, Cr in the 
form of PCr acts as a membrane stabilizer by binding to the phospholipid heads thus not 
allowing for the cytoplasmic contents to dissipate through the cell wall which could lead to an 
increase in cell size.
93
 
The influence of creatine supplementation on muscle creatine stores  
Traditionally, Cr is “loaded’ by consuming 20 g a day for the first five days followed by a 
maintenance dose of 3-5 g per day.
62,94,106,107
  The “loading” of Cr in the system is done to 
rapidly saturate muscle cells with Cr.
26
  In the classic study by Harris et al,
42
 Cr stores increased 
in as little as two days during loading and by the fifth day  had increased by more than  20% 
from pre values.  The maintenance dosage was determined by Hultman et al
48
 who compared a 
loading period followed by either the cessation of Cr supplementation or two grams for the next 
28 days.  They observed a steady decline in Cr stores following cessation, but Cr levels remained 
elevated through 35 days with the two gram/day dosage. Cr may also be taken without loading 
(2-5 g·day
-1
) but in order to saturate the muscle it may take up to 14 days.
48
  The results of these 
studies suggest that Cr stores can be rapidly increased (20-40%)
26,41,48,63,87,88
 during the 
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traditional Cr loading period or gradually increased with lower dosages
48,89
 and once saturated, 
Cr stores can be maintained with  3-5 g·day
-1
.  
 
The influence of creatine supplementation on performance 
The most commonly supplemented form of Cr is Cr monohydrate, consumed by a variety 
of athletes ranging from high school football players to professional track athletes.
61,97,102
  A 
recent review
97
 has suggested that the prevalence of Cr usage is greatest in elite power lifters and 
high school and college-aged football players. Cr supplementation improves maximal 
strength,
5,6,45,58
 vertical jump height,
60
 sports specific skills,
54,82
 running capacity,
63,77
 training 
volume
30
 and delays fatigue.
89,96,99
  The performance enhancing effects of Cr vary depending the 
type of performance (strength vs endurance) and if training is coupled with supplementation.  
The majority of the research
62
  examining the effects of Cr supplementation on performance 
include supplementation protocols lasting between 5-28 days
39,42,48,70,89,107
 and is often combined 
with training.  These increases in performance have been attributed to the ergogenic effects of Cr 
and overall greater training volume.
108
  In theory, if a more readily available energy source is 
present, this will allow for greater training loads and volumes; which may subsequently improve 
performance.  For example, a meta-analysis by Branch et al
13
 has indicated Cr supplementation 
improves work capacity (ES: 0.29), force output (0.29), 1-RM strength (0.32), power output 
(0.20) and sprint times (0.36).  However, it is important to note that fewer studies have examined 
Cr supplementation without training. Cr supplementation alone has demonstrated improvements 
in 1-RM
22,33,100,108,110
, isokinetic
5,39,55,90
 and isometric
34,70,72,103
 strength, sprint  times,
17,24
 vertical 
jump height,
51
  and power
116
.  However, future work is needed to fully understand the potential 
changes in neuromuscular function that may occur following Cr supplementation.     
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The influence of creatine supplementation on neuromuscular function 
Fewer studies have examined the influence of Cr supplementation on neuromuscular 
function
5,52,72,95,104
 without training.  Collectively, the body of literature has reported that Cr 
loading does not improve voluntary isometric strength of the bicep brachii,
7,52,53,104
 
plantarflexors,
95
 or leg flexors,
7,98
 except for the Medeiros et al
72
 who observed a 7% increase in 
leg extension strength.  The discrepancy between the changes in isometric strength may be 
explained in the different muscles being tested, as larger muscles have been shown to respond 
better to Cr supplementation mainly due to their larger mass and demand for Cr.
103
  Cr 
supplementation does however appear to enhance isokinetic strength at fast velocities (180 and 
240 °/sec).5,39,55  Previous authors have suggested that improvements in voluntary strength 
following Cr supplementation may be due to (1) increases in muscle activation, (2) increases in 
intracellular water (ICW) content which may increase muscle size
102
 potentially stimulating 
protein synthesis,
103
 and/or altering pennation angles,
52
 and (3) Ca
2+
 kinetics that may improve as 
Cr buffers ADP allowing for Ca
2+
-ATPase to improve actin-myosin unbinding.
5,104
  Ca
2+
 
sensitivity may also improve with an increase in ICW as it requires less Ca
2+
 to produce the same 
force in a reduced ion environment.
78
  Ca
2+
 kinetics can be indirectly evaluated during evoked 
twitch properties (peak twitch torque and half-relaxation time).   
Muscle activation has been reported to be improved with Cr supplementation as Mederios 
et al. 
72
 observed by an increase in surface EMG amplitude of the leg extensors following Cr 
loading.  However, although they attributed the increase in EMG amplitude to an improved 
neural drive, they did not provide any details regarding their normalization procedures. On the 
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contrary, other studies
52,104
  have indicated Cr loading does not improve percent voluntary 
activation, but may improve conduction velocity
104
 through recruiting faster motor neurons or 
facilitating the uptake of neurotransmitters.
5
  Bazzucchi et al.
5
 previously demonstrated that five 
days of Cr loading improved the torque-angular velocity curve, mean fiber conduction velocity at 
all angular velocities, electrically induced peak twitch force, and the time to reach peak twitch 
force.  However, Smith-Ryan et al
95
 reported no changes in peak torque (PT), peak rate of torque 
development (PRTD) and half relaxation time (HRT) following five days of supplementation in 
women.  Bazzuchi et al.
5
 speculated that the change in neuromuscular function after Cr 
supplementation was contributed to the increased cross bridge cycling rate.  It is possible that 
more readily available ATP, mainly due to the enhanced PCr energy system, increases the Ca
2+
-
ATPase pump therefore increasing cycling rates.
5,104
  These changes may result in a faster 
detachment of actomyosin bridges increasing the capacity to produce force rapidly.
5
 The results 
are still inconclusive since other studies
52,95,104
 have found no significant changes in isometric 
strength, relaxation time, or rate of force development. It is speculated that  Ca
2+
 kinetics maybe 
dependent on the load and type of stimulus
32
, thus in an isometric contraction; where cross 
bridge cycling rate is not a limiting factor, may not be affected.
85
  This would explain why 
Bazzucchi et al. 
5
 observed improvements in isokinetic strength and not isometric strength 
following Cr loading. Additional mechanisms for Cr induced increases in performance may be 
the increase in muscle size
102
 and architectural changes.
52
 For example, Terjung et al
102
 
speculated that “if Cr supplementation was to enlarge muscle volume and this in turn could in 
some manner alter the force/power development; there could be a real enhancement in muscle 
performance.” Jakobi et al52 also suggests that with the increase in cell size from swelling, 
pennation angles could be altered and potentially improve force production.   These findings 
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highlight the need for future studies to further evaluate the influence of Cr loading on 
neuromuscular function.  
The influence of creatine supplementation on range of motion and stiffness 
Even less research has addressed the effect of Cr loading on the extensibility of muscle. 
The only study to date that has examined the influence of Cr loading on flexibility is a recent 
paper by Sculthorpe et al.
92
  They addressed Cr loading on active range of motion and concluded 
that Cr loading limits range of motion during shoulder extension and abduction and ankle 
dorsiflexion movements.  The authors attributed the decreases in flexibility to increases in cell 
size as a result of an increase in intracellular water (ICW) content. The authors speculate that the 
increase in cell size may have led to increases in muscle stiffness and/or altered muscle spindle 
neural outflow. In theory, altered muscle spindles would result in the stretch reflex being 
initiated earlier in the range of motion and potentially decrease maximum range of motion.  Cr 
has the potential to bring water into the cell via its osmotic properties and restrain cytoplasm in 
the cell due to the membrane stabilization of PCr. This increase in cell size is commonly thought 
to reflect the increase in body mass (1 – 3 kg) seen during Cr loading.97  This increase in body 
mass is most likely due to the Cr induced changes in total body water (TBW).  The majority of 
literature
28,56,57,86,97,112,114
 attributes the increase in TBW to increases in intracellular water (ICW) 
credited to Cr pulling water into the cell. Another possible explanation attributes the weight gain 
to an increase in dry matter growth.
28,31
  In theory, increases in muscle cell volume from 
increases in ICW or dry matter would result in a change in muscle viscosity and/or stiffness. This 
was previously suggested by Grazi et al.
35,36
 who noted that any increase in osmotic pressures 
will lead to increases in viscosity and stiffness. Thus, it is possible that if Cr supplementation 
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alters ICW, there would be an increase in passive stiffness which may lead to a decreased range 
of motion and increased risk of soft tissue injury.
113
   
We are aware of only one study that has examined changes in stiffness following Cr 
loading.  Watsford et al
111
  measured active stiffness using the oscillation technique with loads 
ranging from 50-200% of body weight, and found no significant increases in stiffness. This could 
be due to the variability of how the oscillation technique is performed and/or the stiffness 
contributed to muscle cell volume does not play a role in active stiffness.  Recent studies 
91
 have 
employed techniques utilizing powered dynamometers and surface electromyographic measures 
to examine passive stiffness and maximal passive range of motion (ROM).  EMG onset (point of 
which muscle activity becomes detachable during a passive stretch)
11
 is believed to indicate 
muscle spindle activity in response to excessive stretch or load.  If the stretch reflex is altered 
due to increases in muscle size as speculated by Sculthorpe et al,
92
 it is possible EMG onset may 
occur earlier during a passive ROM assessment following Cr loading.  Overall, passive stiffness 
and passive ROM have not been evaluated after Cr loading.  The limited research addressing 
changes in viscosity and stiffness does not allow for a conclusion to be made if the osmotic 
properties of Cr influence ROM and stiffness.  Furthermore, Sculthorpe et al. 
92
 and Watsford et 
al 
111
 failed to determine if changes in fluid distribution actually occurred and if these changes 
may account for the alterations in ROM and/or stiffness.   Recent studies have demonstrated that 
bioelectrical impedance spectroscopy (BIS) is a valid assessment of total body water (TBW) and 
extracellular water 
20,66,76
 (r= 0.80-.97) and can be used to examine changes in fluid distribution 
during Cr supplementation.
114
    To further evaluate the possible changes in muscle cell size as a 
result of Cr supplementation, non-invasive diagnostic tools have been utilized.  For example, 
using magnetic resonance imaging (MRI), Ziegenfuss et al 
116
 reported muscle volume increased 
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after just three days of Cr loading and attributed these changes to an increase in TBW.  
Ultrasonography has been reported to be a valid and reliable measure of muscle size.
1
  Thus, 
ultrasound measurements may offer a unique alternative to MRI techniques to examine the 
changes in muscle size during Cr supplementation.    
Time Course 
Research would indicate when the muscle is fully saturated with Cr
38,42
 and when 
performance is improved
5,55,64
 may occur at different time points. For example, Harris et al, 
42
 
demonstrated that only two days of Cr loading was needed to increase Cr stores by 20% and 
improve maximal leg extension torque production. However, Eckerson et al 
23
 and Law et al 
65
 
demonstrated that two days of loading did not improve anaerobic work capacity or anaerobic 
power and back squat strength, respectively.  Law et al 
65
 reported that a five day loading scheme 
was necessary to enhance strength and power.  Kambis et al 
55
 reported increases in muscle 
performance (isokinetic contractions) just after five days of Cr supplementation. This would 
imply that the mechanisms that are responsible for the improvements in performance may have 
an adaptation period.  There may be a difference from the time that Cr is introduced into the 
system and saturates the cells to when improvements in neuromuscular function are observed. 
Future research is need to simultaneously examine changes in muscle Cr concentrations and 
neuromuscular function. Traditionally Cr concentrations are measured using invasive muscle 
biopsies.
39,42,48,107
  A potential non-invasive technique is proton magnetic resonance spectroscopy 
(MRS)
105
 which has demonstrated to be a valid and reliable assessment of total Cr content in 
skeletal muscle.
12
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Another aspect that has not been fully addressed is the washout period, it has yet to be 
determined if the effects of Cr are permanent or have a residual effect that gradually declines 
after Cr supplementation is discontinued.  To date, there has been limited research that has 
evaluated changes in performance observed during the washout period,
27,48,88
 which would 
provide insight into the possible mechanisms affected by Cr and provide practical dosing 
strategies for practitioners and athletes.  The fundamental study for the majority of the literature 
that addresses the washout period is by Hultman et al,
48
 who loaded with Cr for six days then 
ceased supplementation and tracked muscle Cr levels for 35 days.  Muscle total Cr 
concentrations (both PCr and free Cr) were measured with muscle biopsies of the vastus lateralis 
prior to Cr loading, immediately following loading (day 7), at day 21 and 35.  Total Cr 
concentration was elevated following the loading period but then gradually declined until day 35 
when Cr levels were no different than pre supplementation values.  Another study that examined 
Cr content in skeletal muscle was by Rawson et al
88
 who examined PCr levels in muscle using 
phosphate (31P) magnetic resonance spectroscopy prior to and following a five day loading and 
following a 30 day washout period.  A 45% increase in PCr stores was observed following Cr 
loading, and after the 30 day washout period PCr levels remained 23% above pre-
supplementation levels. The discrepancies between these studies maybe related to the type of Cr 
stores examined. For example, Hultman et al
48
 measured both PCr and free Cr, and it appeared in 
their tables that free Cr was returning to baseline but PCr remained elevated even up to day 35.  
This would then be in line with Rawson et al
88
 who indicated that PCr will remain elevated 
following Cr loading.  
To date minimal research has addressed the washout period and it implication on 
performance.  For example, Febbraio et al 
27
 examined one minute intermittent cycling 
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performance following Cr loading and a 28 day washout period.  Despite increases in 
intramuscular creatine stores following Cr loading, supplementation had no influence on 
performance at either time point.  This study found that after 28 days, total Cr levels returned to 
normal, but failed to shed any light on the washout effect on performance since loading was 
insufficient at increasing performance. Most research only addresses Cr loading and fails to 
monitor the time course effects that Cr may have, thus if the possible underlying mechanisms are 
affected we do not know if the results are permanent or if they gradually diminish as Cr is slowly 
returns to baseline values. Thus, the effects of Cr loading on neuromuscular function and the 
possible implication with the cessation of supplementing (washout) warrants further 
investigation.   
Statement of purpose 
Although Cr is one of the most studied supplements to date, some of the fundamental 
questions on how Cr influences performance are still left unanswered.  The underlying 
mechanisms that are believed to be responsible for the increases in performance have failed to be 
determined by the literature.  The current literature only speculates Cr’s effect on neuromuscular 
function, ROM and stiffness. One common implication is the idea of an increase fluid retention 
and swelling of cells. Yet the majority of the research fails to measure water distribution and 
muscle Cr content.   Therefore, the purpose of this study was to determine the effects of Cr 
supplementation on muscular strength and ROM during and following a traditional loading 
period and subsequent washout.   
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Specific Aims 
Specific Aim 1: To determine the effect of Cr supplementation on voluntary isometric and 
isokinetic strength during a traditional loading period and the subsequent washout.  
We hypothesize that isokinetic strength at the fastest velocity (180º·s
-1
) will increase after five 
full days of Cr loading then return to baseline by the 35
th
 day.  The increase in isokinetic strength 
will be accompanied by a decrease in evoked twitch half-relaxation time, none of the other 
variables will differ from that of those observed by the control group and will remain the same 
throughout the washout period. 
Specific Aim 2: To determine the effects of Cr supplementation on active and passive ROM 
during a traditional loading period and the subsequent washout.  
We hypothesize that active ROM will be reduced following five days of Cr supplementation and 
return to baseline by the 35
th
 day.  These changes will be accompanied by an increase in TBW, 
ECW and ICW and subsequent increase in muscle size, however, passive ROM, stiffness, and 
the onset of EMG activity will not differ from that of those observed by the control group and 
will remain the same throughout the washout period  
  
 12 
 
 
CHAPTER II 
REVIEW OF THE LITERATURE 
This review of the literature is not an all-inclusive list of studies examining Cr 
supplementation on physiological function, but rather highlights the current literature examining 
Cr supplementation (without training) on neuromuscular function. This review will focus on 
studies that have specifically used the twitch interpolation technique, resting evoked twitches, 
isokinetic and isometric testing, and measures of ROM and stiffness as it pertains to Cr 
supplementation.  In addition, key articles describing the physiological role of Cr 
supplementation are included.  Lastly, a table is provided in the appendix that includes studies 
that are most relevant to the current research questions.   
The influence of Cr supplementation on neuromuscular function 
Bazzucchi I, Felici F, and Sacchetti M (2009)  
The purpose of this study was to evaluate the effects of short term Cr supplementation on 
muscle contractile properties, the force-velocity relationship and muscle fiber conduction 
velocity. Sixteen moderately trained males (25 ± 5 yrs) were either given Cr monohydrate (n=8) 
or maltodextrin (5 days, 20 g/day).  Isometric MVC, max twitch force, isokinetic contractions 
(15, 30, 60, 90, 120, 180, & 240 º·s
-1
) and fatigue of the elbow flexors were measured prior to 
and following supplementation. Tests were conducted on an isokinetic dynamometer with the 
elbow axis of rotation aligned with the center or the lever arm.  Force was measured from a load 
cell strapped to the wrist.  EMG of the biceps brachii was recorded to evaluate conduction 
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velocity via the cross-correlation technique.  The fatiguing protocol consisted of five sets of 30 
isokinetic (180 º·s
-1
) contractions.  Following supplementation twitch peak torque increased, and 
time to peak torque decreased (P<0.05).  Isokinetic peak torque was significantly increased at 
180 and 240 º·s
-1
 (P<0.05) from pre to post.  Conduction velocity was increased following 
supplementation at all velocities (P<0.05). There was no difference between pre and post peak 
torque values during the fatiguing protocol. The authors concluded that Cr supplementation 
improves neuromuscular function of the elbow flexors as an increase in torque was observed at 
higher velocities. They speculated that the increase in performance is a result of improvement in 
Ca
2+
 kinetics which is contributed to the increase in available ATP. They also demonstrated that 
Cr may have a neurological effect that needs further study.  Surprisingly the study did not 
observe differences in any of the fatigue measures, the authors hypothesize that the factors that 
are positively influenced by Cr supplementation are not the same as the ones negatively affected 
by fatigue.  
Bembem MG, Tuttle, TD, Bembem DA, and Knehans AW (2001)  
The purpose of this study was to examine the effect of Cr supplementation on the force 
time curve of an isometric contraction of different muscles. Nineteen healthy sedentary males 
consumed 20g of either Cr monohydrate (n=11) or corn starch (n=8) for five days followed by a 
maintenance dose of five grams for five days. All testing was done on an isometric testing cage.  
Elbow flexion and extension were conducted at 90º of flexion with the palm supinated for 
flexion and pronated for extension.  Knee extension and flexion was performed at 90º of knee 
flexion. A load cell was appropriately placed on the wrist or ankle to measure force output. Three 
MVCs at each joint were held for three sec with one min rest between each contraction. 
Following the isometric MVC, an endurance task consisting of 14 isometric MVCs with two sec 
 14 
 
rest were performed. All isometric tests were completed on the same muscle group before 
moving on to the next.  The force time curve for each contraction was analyzed to determine 
maximal force (MF), maximal rate of force development (MRFD), time to max force (TMF), 
impulse of max force (IMF), total impulse (TI) and from the endurance tasks they calculated 
percent force decrement. No significant difference (P> 0.05) between groups was found for MF 
(pre: 246, post 232N), TMF, and MRFD (pre: 782, post 853 N·s
-1
). For the endurance task, there 
was no significant difference for TI and PFD. There was a time effect found for both groups as 
both groups improved from day one to day 10. The authors of this study concluded that Cr 
supplementation alone does not bring about any changes in isometric force production after 10 
days of supplementation. They believed that the positive effects of Cr supplementation can be 
attributed to its ability to increase work capacity and must be paired with weight training to 
maximize the effects.   
Deutekom M, Beltman JGM, de Ruiter CJ, de Koning JJ, and de Haan A (2000) 
The purpose of this study was three fold, the first objective was to determine if short term 
Cr loading effects power output during whole body performance; the second objective was to 
investigate the effect of Cr loading evoked peak torque and rate of torque development, and the 
third objective was to address the influence of Cr loading on fatigue during electrically 
stimulated contractions of the quadriceps.  Well trained rowers were given five grams of either 
maltodextrine (n=12) or Cr monohydrate (n=11) four times a day for six days. Testing was 
conducted prior to and following the supplementation period. Evoked twitch properties were 
conducted using surface electrodes placed on the quadriceps and were stimulated until 30% of 
the force generated during a maximal isometric contraction was reached.  Isometric contractions 
were conducted using a force transducer strapped to the leg with the knee flexed to 90º.  Five 
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maximal contractions were performed followed by the electrical stimulus at 10, 20, 50, 100, 150 
& 200 Hz.  The sequence of the stimulus was randomly ordered and one min of rest was given 
between each contraction.  For total body fatigue two 30s sprints on a cycle ergometer was used 
to determine power output.  Cr loading demonstrated no effect on maximal contractions (pre: 
305, post 298 Nm), muscle activation, or power output during the cycle ergometer fatiguing task.  
The authors concluded that Cr supplementation did not significantly affect torque production or 
the rate of torque production and fatigue or recovery from fatigue.  
Greenhaff PL, Casey A, Short AH, Harris R, Soderlund K, and Hutlman E (1993) 
The purpose of this study was to examine the effect of Cr supplementation on torque 
production during repeated bouts of maximal isokinetic contraction.  Twelve college students (9 
males, 3 females) consumed 20g (5 x 4 serving) per day for five days of either glucose (n=6) or 
Cr monohydrate (n=6).  Participants reported to the lab on a two occasions for initial testing and 
following the five days of supplementation.  Testing included five sets of 30 maximal voluntary 
leg extensions at a constant angular velocity of 180 º·s
-1
 with a minute rest between each set.  
Blood draws were also taken before testing, after the warm up, between each set, immediately 
post, and two, five, and 10 minutes post exercise. At baseline both groups were similar in peak 
torque production and both had a similar decline in toque production during the repeated 
isokinetic muscle actions.  There was no difference (P > 0.05) in the decline (~50%) between pre 
and post supplementation with the placebo group; however the participants that supplemented 
with Cr maintained higher levels of torque across all five sets post supplementation.  The Cr 
group generated significantly more torque during the second (P < 0.001) and third (P < 0.05) 
exercise bouts than the placebo group.  There was no difference in blood lactate levels after 
exercise between groups, or pre and post supplementation, but the Cr group had less ammonia 
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accumulation post supplementation.  The authors speculated that the low amount of ammonia 
acumination and the muscles ability to maintain higher levels of peak torque was the result of 
more available Cr due to supplementation and its ability to phosphorylate ATP via the PCr cycle. 
In conclusion Cr supplementation did not improve peak torque production but aided in 
maintaining torque levels through a fatiguing task.  
Hamilton KL, Meyers MC, Skelly WA, and Marley RJ (2000) 
The purpose of this study was to investigate the influence of Cr on upper body strength 
and fatigue in women who participate in overhead sports.  Females were given either 25 g of Cr 
monohydrate  (n=11) or a placebo (n=13) for seven days.  All testing was conducted prior to and 
following supplementation.  All participants performed elbow flexion and shoulder internal 
rotation on a powered isokinetic dynamometer.  For elbow flexion the following tests were 
performed: concentric and eccentric isokinetic flexion at 90 º·s
-1
, an isotonic 1RM, and a 
fatiguing protocol which consisted of performing as many repetitions to failure at 70% of 1RM.  
For shoulder internal rotation an isotonic 1RM, one isotonic max velocity test at 25% of 1RM, 
and the fatiguing protocol were performed.  Two min of rest was given between all tests.  The 
isokinetic testing of the elbow flexors yielded no significant change in eccentric (Pre: 62, Post 64 
Nm) or concentric (Pre: 4, Post: 46Nm) torque values following supplementation.  Reps to 
fatigue for the elbows flexors was significant increased (P<0.05, 12-16 reps) from pre to post 
supplementation in the Cr group.  There were no significant changes in 1RM or reps to fatigue (P 
< 0.05) for the internal rotators.  The results of this study determined that only isotonic work to 
fatigue was improved with Cr supplementation.  None of the other variables measured showed 
significant changes from pre to post supplementation or differed from the placebo. In conclusion 
the authors determined that short term Cr supplementation with no formal training does not 
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improve upper extremity strength measurements, thus explosive overhead athletes may not 
benefit from Cr supplementation alone. The authors speculated that Cr’s effects would have been 
larger had supplementation been part of a training program.   
Jakobi JM, Rice CL, Curtin SV, and Marsh CD (2000) 
The purpose of this investigation was to determine if short term Cr supplementation 
would alter the neuromuscular response prior to and following a fatiguing task. Fourteen young 
males (22 ± 3 yrs) were either given either 20 grams of Cr monohydrate (n=7) or maltodextrin 
for 5 days.  Prior to and following supplementation, participants performed a twitch interpolation 
technique that consisted of an isometric contraction of the elbow flexors (90º of elbow flexion) 
with a superimposed twitch, followed by resting twitches.  Prior to and following a fatiguing 
task, tetanic twitches were administered at 50Hz.  The fatiguing task consisted of repeated bouts 
of six second isometric contractions at 50 % maximum force production with four seconds of 
rest until 50% of maximum force could no longer be achieved.   Force output was measured via a 
strain gauge that was tethered to the floor and attached to the wrist.  From the twitch 
interpolation technique, percent activation, peak torque, time to peak torque, half relaxation time, 
EMG amplitude, contraction duration where calculated.  Tetanic tension and tetanic relaxation 
time were calculated prior to and following the fatiguing task.  Time to fatigue was also 
measured as the time at which 50% of maximum force could not be achieved.  The Cr group was 
not significantly different from the placebo group at any measure pre or post supplementation.  
There was a 44% reduction in peak force during the fatiguing task (P<0.05) combining the 
groups.   Following the fatigue protocol, there was a 10% decrease in muscle activation and an 
increase in relaxation time in the resting twitches for both groups (P<0.05).  The results of this 
study indicate that Cr supplementation does not alter maximum strength and evoked twitch 
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properties following a fatiguing bout of exercise.  The authors speculate that muscle metabolism 
and muscle force are independent of each other; Cr supplementation positively influences the 
metabolic properties of muscle but may not influence the mechanical properties.  
Kambis KW and Pizzedaz SK (2003)  
The purpose of this study was to investigate the effect of Cr supplementation on power 
and torque output of the quadriceps.  Twenty-two healthy college aged women were matched 
according to diet, menstrual phase and exercise history then given 0.05g·kg-1 a day of either a Cr 
monohydrate or a placebo.  The supplement was consumed in four equal servings per day for 
five days.  Participants completed all testing prior to and following supplementation.  
Participants completed five consecutive maximal isokinetic muscle actions of the leg extensors 
and flexors at 60 º·s
-1
.  Participants then rested five minutes before completing 50 maximal 
contractions at 180 º·s
-1
.  During the isokinetic testing, power output and time to peak torque 
were examined.  There was as an increase in power output across the 50 isokinetic contractions 
at 180 º·s
-1 
for both flexion (6.0 W) and extension (9.1 W) (P< 0.05) following Cr 
supplementation.  Time to peak torque for leg extension decreased 2.2ms following Cr 
supplementation (P< 0.05).  In the placebo group, there were no changes in any measure during 
the 50 contractions pre to post.  There was no difference in any of the measures at 60 º·s
-1
 
between groups or pre or post supplementation (P=0.05).   In conclusion, Cr supplementation 
improves muscle performance in women at faster velocities of leg extension but does not 
influence muscle performance during low velocity isokinetic muscle actions.  The authors 
contribute these differences to the recruitment pattern of muscles at high velocities in which fast 
twitch fibers are recruiter more thus type II fibers, which rely heavily on the PCr systems, would 
more likely benefit from supplementation.  
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Law YLL, Ong WS, GillianYap TL, Lim SCJ, and Von Chia (2009) 
 This study was included in the literature review based of the fact that it is the only study 
to date the addresses different days within the Cr loading period on muscular function, however, 
the Cr supplementation was coupled with eight resistance exercises on day one and four.   The 
purpose of this study was to address the effect of two and five days for Cr loading on muscular 
strength and anaerobic performance.  Participants either consumed 20 g of Cr (n=8) or a placebo 
(n=9) for five days. One repetition maximum (1RM) bench press and squat exercises were 
conducted with the ascending weights on a smith machine working up to a 1RM.   Power was 
determined from a 30s Wingate anaerobic power test.  All testing was conducted prior to and 
following two and five days of supplementation. There was no improvement in strength (P>0.05) 
or power (P>0.05) after two days of supplementing. There was however, a significant increase in 
the 1RM squat strength following five days of supplementation (P<0.05). Average power also 
improved following five days (P<0.05) of Cr use.  The authors concluded that it takes at least 
five days for Cr to influence measures of strength and power. The improvements in performance 
seen with Cr supplementation may take longer to manifest then it takes Cr to enter the cell. This 
research indicates there may be a saturation level that must be reached to improve performance 
or that there must be is a delay in Cr uptake by the cells to when it improves cellular function.
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Medeiros RJD, Santos AAd, Ferreira AdCD, et al. (2010) 
The purpose of this study was to examine the effect of Cr loading on maximal isometric 
strength and EMG amplitude in women.  Twenty seven women (23±2 years) consumed either 20 
grams of Cr monohydrate (n=13) or maltodextrin (n=14) for 6 days.  Isometric leg extension 
strength was tested at 120º of leg extension of the dominate leg using a powered dynamometer 
with EMG electrodes placed on the vastus lateralis.  Three maximal isometric knee extensions 
were performed for six seconds with 180 seconds rest between trials.  For each trial, peak torque 
and max EMG amplitude were analyzed as well as the mean of the three trials.  Comparisons 
were done between pre and post measures of isometric strength and root mean squared EMG 
amplitude.  A significant increase (P= 0.002) in isometric strength from pre to post (~7.85%) 
was found with Cr supplementation but not the placebo. The significant increase in isometric 
strength of the participants who supplemented with Cr was accompanied by a significant (P= 
0.026) increase in EMG amplitude (~15μV).  The authors conclude that Cr supplementation 
alone does have the ability to increase isometric force production, and this was accompanied by 
an increase in EMG amplitude. The authors acknowledge that increase in EMG does not 
necessarily coincide with an increase in strength.  The authors attribute the increase in EMG 
amplitude to an increase in recruitment of motor units and/or firing frequency, but failed to 
normalize or provide any mechanisms behind the increases in EMG amplitude and torque 
production.  
Rawson ES, Clarkson, PM (2000) 
The purpose of this study was to examine the effects of short term Cr supplementation in 
older adults on isokinetic leg extension strength and isometric strength of the elbow flexors. 
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Seventeen older males (65 years) were given 20 grams day of either Cr monohydrate (n=9) or a 
placebo (n=8).  The supplement was consumed in four equal servings per day for five days.  
Participants complete all strength testing prior to and following supplementation.   Isometric 
elbow strength was tested on a preacher curl bench with the humerus against the pad and the 
hand grabbing on to a bar that was attached to a strain gauge.  Leg extension peak torque was 
measured during three sets of 30 maximal concentric leg extensions at 180 º·s
-1
 on a isokinetic 
dynamometer.  The sum of the peak torque values per set were used as a measure of strength.  
Following the five days of supplementation peak torque increased 25.2Nm for the second set and 
72.6Nm for the third set for leg extension strength (P <0.05) in the Cr group, but not differ from 
the placebo group.  There was no significant change in elbow strength (P >0.05) for either group.  
In conclusion, the authors determined that supplementing with Cr does not increase upper or 
lower body strength. The authors suggest the Cr kinetics may be reduced in an elderly population 
which could be one reason why there was not an improvement in strength.   
Rossouw F, Kruger PE, and Rossouw J  (2000)  
The purpose of this study was to evaluate the effects of Cr supplementation on deadlift 
and isokinetic leg extension performance in well trained power lifters.  Thirteen well trained 
power lifters were administered nine grams of either Cr monohydrate (n=8) or sucrose (n=5) for 
six days.  Isokinetic leg extensions were performed prior to and at day five of supplementation, 
and a 1RM deadlift was done prior to and at day six of supplementation.  The isokinetic testing 
consisted of three sets of 25 isokinetic leg extensions at 180 º·s
-1
.  Peak torque, peak power, work 
and work from reps 1-5 and 21-25 were calculated for leg extension performance.  Deadlift was 
measured as the maximum amount weight lifted according to competition standards.  Both 
groups experienced an increase in isokinetic strength following the five days of supplementation 
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(P=.01−.05), but the Cr group experienced an increase (P=0.01) in power during the third set 
while the placebo did not.  The Cr group deadlifted 7.81±7.95 kg more than they did prior to 
supplementation (P=0.02), the placebo group did not significantly lift more (P=0.20).  The 
results of this study indicate that even well trained lifters may benefit from Cr supplementation 
as it improved some markers of isokinetic strength and deadlift performance.  
Smith-Ryan AE, Ryan ED, Fukuda DH, Costa PB, Cramer JT, and Stout JR (2013)  
The purpose of this study was to examine the effects of fatigue on neuromuscular 
function following Cr loading.  This study addressed the issue of Cr’s ability to prolonged 
fatigue, but since fatigue is not part of this review, the focus will be on measures pre and post 
supplementation prior to the fatiguing task.  Twelve females consumed 20 grams of fructose with 
either five grams of Cr monohydrate or a placebo four times a day for five days.  Maximal 
isometric plantar flexion strength was performed prior to and following five days of 
supplementation on a custom made force plate.  During the maximal voluntary contraction 
(MVC) the twitch interpolation technique was used to determine percent voluntary activation and 
peak force.  From the resting twitches, peak twitch force, peak rate of force development, half 
relaxation time, and M-wave amplitude of the soleus and medial gastrocnemius. There were no 
differences between the placebo and the supplement group in any of the neuromuscular measures 
(P=0.805 −0.064) (MVC, peak RFD, relaxation time and RMS).  The results of this study 
indicate that short term Cr supplementation does not influence isometric measures of strength or 
evoked twitch properties of the lower leg in women.  In conclusion, isometric strength may not 
be an appropriate measure to evaluate the muscles ability to use Cr.   
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Stevenson, SW and Dudley GA (2001) 
The purpose of this study was to address the effects of Cr loading on fatigue, dynamic 
resistance exercise performance, voluntary and evoked isometric strength.  Thirty one resistance 
trained males (n=29) and females (n=20) consumed either 20g of Cr monohydrate (n=18) or a 
placebo (n=13) per day for five days.  Participants performed all tests prior to and following five 
days of supplementation.  Five maximal isometric contractions were performed with the leg 
extensors at 45º below the horizontal plane on a dynamometer.  Five repetitions of electrically 
stimulated contractions were performed at 70% of maximal torque.  Leg extension one maximal 
repetition (1-RM) and repetitions to failure were conducted on a leg extension machine.  The 
load for the repetitions to failure test was subjective but remained the same for pre and post 
testing.  From both voluntary and evoked isometric contractions, rate of torque development and 
relaxation time were calculated.  Rate of torque was calculated during 20-80% of the maximal 
torque.  Cr supplementation did not significantly improve rate of torque development (P=0.0807 
Pre: 801, Post: 753N·m·s-1) and was not different from the placebo.  There was no significant 
difference in relaxation time (pre: 30, post: 29 ms), 1 RM strength, or repetitions to failure 
between groups.  The authors concluded that short term Cr supplementation in resistance trained 
men does not improve leg extension rate of force development, relaxation time or fatigability.  
Urbanski RL, Loy SF, Vincent WJ, and Yaspelkis BB (1999)  
The purpose of this investigation was to determine if Cr supplementation improves 
maximal isometric strength and time to fatigue following loading.  Ten males (26±6 years) 
consumed either 20 g of Cr monohydrate or a placebo for five days, then following a 35 days 
washout period were given the opposite supplement they previously received for five days.  The 
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crossover design of this study allowed for all 10 participants to be given both the placebo and Cr.  
Isometric strength tests were performed prior to and following both supplementation periods (5 
days).  Isometric leg extension strength was examined on a dynamometer with the leg flexed at 
90º.  Isometric grip strength was performed with the arm by their side and flexed to 90º on a 
hand held dynamometer.  Time to fatigue was measured by having the participant perform three 
trials of isometric holds at 67% of MVC for as long as possible for both the leg extension and 
grip exercise.  Isometric peak strength and time to fatigue were recorded and compared between 
the placebo and Cr.  Cr supplementation increased (~2 Kg·m) isometric leg extension strength 
(P<0.05) but failed to increase hand grip strength.  Time to fatigue was significantly increased 
(P<0.001) for both leg extension and grip strength following Cr supplementation when compared 
to the placebo during all three bouts (~3s).  The authors attributed the increase in time to fatigue 
to the more readily available sources of ATP via the PCr system as a result of Cr 
supplementation.  The authors concluded that Cr supplementation improves performance when 
ATP is a limiting a factor, and may be more beneficial in larger muscles. 
van Leemputte M, Vandenberghe K, and Hespel P (1999) 
The purpose of this study was to evaluate the effect of Cr supplementation on voluntary 
isometric torque and relaxation time.  Sixteen males (18-23 years) were asked to consume either 
20 grams of Cr monohydrate (n=8) or maltodextrin for five days.  Participants performed all tests 
of the elbow flexors prior to and following the five days of supplementation.  Testing began with 
three isometric MVCs of the elbow flexors at 110º of flexion on a dynamometer and held for 
three seconds.  Following the MVCs, participants performed twelve consecutive MVCs with 10 
seconds rest intervals and EMG was recorded to muscle activation.  Over the course of the 
twelve contractions, peak torque and relaxation time were calculated.  Relaxation time (RT) was 
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calculated as the time course of isometric torque decay from 75 to 25% of maximum torque. 
Muscle activation was the normalized peak EMG amplitudes during the initial contraction (25-75 
% of peak torque) and during RT.  Cr supplementation had no effect on peak torque during the 
12 contractions (pre: 57Nm, post: 58Nm).  Cr supplementation did reduce (~20%)  RT during 
the 12 contractions while the placebo did not (P<0.05).  There was also no significant change in 
muscle activation between groups.  The authors attribute the decrease in RT to an increase in 
Ca
2+
 kinetics due to an improvement in the PCr system as a result of Cr supplementation.  The 
authors attributed the lack of change in peak torque was a result of the  fiber composition of the 
bicep muscle group being an equal distribution of fiber type, not primary type II which would 
utilize more Cr.  In conclusion, short term Cr supplementation shortens relaxation time during 
brief isometric contractions.  
The influence of Cr supplementation on ROM and muscle stiffness 
Sculthorpe N, Grace F, Jones, and Fletcher I  (2010) 
The purpose of this study was to determine the effects of Cr loading on joint range of 
motion. Forty healthy young participants (24±3yrs) consumed either 25grams of either Cr (n=20) 
or a placebo (n=20) for five days then five grams for the remaining three days.  Prior to and 
following supplementation, active range of motion (ROM) assessments were taken with a 
universal goniometer.  The tests consisted of: shoulder flexion, extension, lateral & medial 
rotation and abduction; elbow flexion; hip: flexion, extension abduction, medial and lateral 
rotation; ankle plantar and dorsiflexion.  The results showed that the control group’s ROM did 
not differ from pre to post (P < 0.05).  The Cr group had significant decreases in ROM for 
shoulder extension (15.8%, P < 0.01; effect size = 0.371), shoulder abduction (1.7%, P < 0.05; 
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ES = 0.25) and ankle dorsiflexion (14.8%, P < 0.01; ES = 0.301). The authors concluded that 
ROM was affected by Cr supplementation in joints where smaller muscles were working against 
larger antagonist muscles.  There was no change in ROM in joints with larger agonist muscles.  
The authors determined that altered ROM was not due to an inhibition in the active muscle but 
an enlargement in size of the antagonist muscle. The authors contributed the increase in size of 
the antagonist muscle to the fluid shift that occurs with Cr supplementation.  The authors 
speculate that the increase in size of the antagonist muscle would trigger the stretch reflex sooner 
as it is lengthening during the active ROM causing a contraction of the antagonist muscle leading 
to a reduction in active ROM in the smaller agonist muscle. 
Watsford ML, Musphy, AJ, Warwick, SL and Walshe ED. (2003) 
The purpose of this study was to examine the effects of Cr supplementation on 
musculotendionus active stiffness, isometric force and jump performance.  Twenty men 
consumed either 20 grams of Cr (n=10) or a placebo (n=10) for seven days then consumed 10 
grams a day for 21 days.  Testing was conducted prior to loading, following loading (day 7) and 
after the supplementation period (day 28).  Active stiffness of the plantar flexors was determined 
by using the oscillation technique measuring peak to peak distance at 50, 100 and 200% of body 
weight.  Isometric contractions of the plantarflexors were performed with participant in a seated 
calf raise position with the knees and hips bent to 90° of flexion with a load cell placed between 
the ground and the movable arm of the calf raise machine. Countermovement and drop jumps 
from 80 and 100cm were used to determine jump performance.  Addressing only the time point 
following the loading period (day 7) there was no significant influence of Cr supplementation on 
active stiffness at 50% of body weight (pre: 3,463.7; post: 3,440.1 N·m
-1
), 100% (pre: 5,199.7; 
post: 5,275.7 N·m
-1
), or 200% (pre: 8,147.7; post: 7,519.3 N·m
-1
), using the oscillation 
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technique.  There was no significant change (P > 0.05) in isometric force (pre: 2,908.8; post 
2,958.5N), RFD (pre: 11,677; post: 11,356 N·s
-1
), and jump performance following seven days 
of Cr supplementation.  As a result, the authors concluded that Cr supplementation does not 
influence isometric strength or jump performance.  The authors hypothesized that an increase in 
water retention with Cr, as observed in previous literature, would alter the muscles size and thus 
affect stiffness.  These results would indicate that there is no influence of Cr supplementation on 
active stiffness.  Based on these findings Cr supplementation did not influence any performance 
measures or an increase in active stiffness after seven days of loading.  
 
The influence of Cr supplementation on fluid distribution 
Bembem. MG. Tuttle, TD., Bembem DA. And Knehans AW. (2001)  
The purpose of this study was to address the effect of Cr supplementation on the force 
time curve during an isometric contraction of different muscles.  The secondary purpose was to 
address the possible fluid shifts during supplementation.  Nineteen healthy sedentary males 
consumed either 20 grams of either Cr (n=11) or corn starch (n=8) for five days, then a 
maintenance dose of five grams for five days.  The fluid shift was examined using bioimpedance 
spectroscopy. Total body water and intracellular and extracellular water were calculated with a 
Xitron BIS analyzer system and examined pre and post supplementation.  There was no 
significant difference between the pre and post-testing body water measures (P> 0.05).  There 
was a trend in the Cr group, as all three body water measures increased while the placebo group 
remained unchanged. The authors concluded that ten full days of Cr maybe enough time for the 
body to rebalance water distribution following Cr supplementation. Cr’s osmotic properties may 
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influence water shift during the initial loading period but may return to balance after continued 
supplementation.  
 
Kern M, Podewils L, Vukovich M, and Buono M (2001) 
 The purpose of this study was to evaluate body water changes in relation to gains in body 
weight following Cr supplementation and to determine if Cr benefits thermal regulation capacity 
in the heat.  Twenty healthy males consumed either 21 grams of Cr monohydrate (n=11) or sugar 
(n=8) for five days then two grams a day for 23 days.  Total body water was determined using a 
bioelectrical impedance analysis and was measured weekly for the 28 days.  Body composition 
was measured using hydrostatic weighing with the Siri equation. VO2 max was determined on a 
cycle ergometer prior to supplementation and following the 28 days.  A 60 minute of cycle 
ergometer test was performed at 60% VO2max in the heat (37º C).  Core temperature was assessed 
prior to and during the cycling.  There was no difference in any of the pre values between the 
groups (P=0.484).  Subjects that supplemented with Cr demonstrated an increase in lean mass 
and body mass after the 28 days. There was a corresponding gain in TBW with the Cr group, 
which was associated with the increase in body mass. The core temperature rose in all conditions 
but was lower in the Cr group pre and post supplementation but was not significantly different 
during the cycling test (P=0.057). The authors concluded that the increase in body mass is 
attributed to the increase in water during Cr supplementation, and thus an increase in TWB 
would in theory improve heat buffering in the body when exercising in high temperature 
conditions.  Even though the results were insignificant, a decreasing trend in body temperature 
during the 60 min cycling following Cr supplementation suggests it may be beneficial when 
exercising in the heat.   
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Powers ME, Arnold B, Weltman AL, Perrin DH, Mistry D, Kahler D (2003) 
 The purpose of this study was to investigate the effects of Cr supplementation on Cr 
concentrations in the muscle and fluid volumes using direct measures.  Sixteen males and 16 
females who regularly performed resistance training participated in this study.  Subjects reported 
to the clinic the first day and stayed overnight.  During their stay they had their resting vitals and 
fluid volumes, urinary Cr and muscle Cr levels taken.  Participants were stratified by gender then 
randomly given either a placebo or Phosphagen supplement containing five grams of Cr 
monohydrate.  The supplement was taken five times a day for seven days then once a day for the 
next 21 days. They were then post tested at day seven and 28.  Urinary Cr levels were taken from 
the urine collected during the overnight stay.  Muscle biopsies from the vastus lateralis were used 
to address Cr stores in the muscle.  Fluid volumes were measured using deuterium oxide (D2O) 
dilution for TBW and sodium bromide dilution for ECW and ICW volumes.  BIA was also used 
to with the D2O values.  There was no difference in baseline urinary Cr levels but there was a 
significant increase in Cr in the urine in the supplement group (P= 0.023), Cr stores in the 
muscle also increased during the supplementation in the Cr group (P= 0.023), but not the placebo 
group. There was not a significant increase in body mass (P<0.05) at day seven but there was an 
increase in body mass by day 28 (P=0.044).   For fluid distribution, there was an increase in 
TBW with both groups but the Cr group had a significantly higher increase in TBW (P=0.027). 
There was no significant difference between groups at any time point for ECW or ICW 
(P=0.366).  In conclusion, Cr’s osmotic properties increase the body’s ability to retain water as 
measured with an increase in TBW this coincides with an increase in muscular Cr stores increase 
with supplementation.  The primary finding is that Cr does not affect fluid distribution as seen 
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with no change between ECW and ICW.  Thus, the authors conclude that Cr increases overall 
water carrying capacity but does not affect how it is distributed.  
Weiss BA, and Powers ME (2006) 
 The purpose of this study was to determine if an acute Cr supplementation alters fluid 
distribution and thus impairs thermoregulation during a bout of exercise in greater thermal 
temperatures. Twenty-four male participants consumed either 25 grams of Cr monohydrate 
(n=12) or a placebo (n=12) for five days.  Prior to and following the supplementation period, 
participants had their body mass, heart rate, body water volumes and core temperature measured. 
Participants then performed a graded exercise test on cycle ergometer in a 37º C temperature 
control room.  During exercise, HR, sweat loss, and core temperature were taken every 10 
minutes during the 60 minute test. Water volumes were measured using bioelectrical impedance 
spectroscopy. There was no significant difference between the Cr and placebo groups in HR 
(P=0.754), sweat loss (P=0.144), or core temperature (P=0.870).  There was a significant 
increase in TBW (p=0.004), ECW (p=0.005) and ICW (p=0.046), in the Cr groups following five 
days of supplementation while the placebo group exhibited no change.  The results showed that 
Cr supplementation does influence water retention but does not unequally distribute fluid within 
the body.  Cr increased water content in the body but did not have any adverse effects on the 
sweat response or core temperature. The concerns that Cr’s osmolality properties may cause a 
fluid shift resulting in less sweat loss were shown to be invalid as a result of this study.  The 
authors concluded that Cr supplementation maybe beneficial in maintaining proper temperature 
of the body during prolonged exercise. 
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Ziegenfuss TN, Lowery LM, and Lemon PW. (1998) 
 The purpose of this study was to estimate the relative fluid volumes during three days of 
Cr supplementation.  Ten healthy males consumed 0.07g·kg·FFM
-1 
of Cr five times a day for 
three days.  Prior to and following supplementation baseline values of FFM, body fat percentage; 
TBW, ECW, and ICW were measured for three days. Bioelectrical impedance analysis was used 
to determined fluid distribution.  Following three days of supplementation there was an increase 
in TBW (P= 0.07), and ICW (P<0.05), but there was no significant change in ECW (P= 0.51). 
The authors suggest that even though there was a small significant change in fluid volumes this 
change was not large enough to influence other variables associated with increases in cell size 
like protein or glucose synthesis.  The authors calculated effect size for TBW and ICW and they 
were 0.39 and 0.64, respectively.  In conclusion, even though the significant changes in fluid 
volumes were small, they may have small to moderate effects on fluid distribution.  
  
The physiological role of Cr supplementation  
Harris RC, Soderlund K, and Hultman E. (1992) 
 The purpose of this study was to determine if Cr supplementation would be absorbed by 
human tissue and whether absorption would increase with continued supplementation. This is the 
first study that addressed Cr absorption in human muscle. Five females and 12 males between the 
ages of 20-62 participated in this study.  Twelve of the participants consumed 4 × 5 g a day for 
4.5 days.  At that point two participants stopped consumption, while the remaining participants 
consumed Cr for either 7, 10 or 21 days total days. This design was to address how long it took 
for Cr to saturate muscle.  Muscle biopsies of the vastus lateralis where taken prior to 
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supplementing and following day two and at the completion of each of the supplementation 
periods.  Plasma was taken from a subset of the participants for seven hours following one 
serving of five grams of Cr. Urine samples were taken from most of the subjects to measure Cr 
excretion.  Cr supplementation resulted in an increase in plasma levels, which peak one hour 
following Cr ingestion and slowly decline until five hours post consumption.  Only four subjects 
completed the full urine analyses. The results of the urine analysis indicated that during the first 
two days, 32% of Cr ingested was absorbed and the rest was excreted.  This number then 
dropped to 17% from the second to forth day. The result of the muscle biopsies indicated that Cr 
supplementation increases muscle concentration of Cr but the level of uptake varied between 
participants.  Participants with higher initials level of Cr stores had a smaller increase in Cr 
stores then someone with lower initial levels. This indicates that there is a saturation level that 
occurs in most people around ~145mmols·kg
-1
 of wet weight. The participants that had muscle 
biopsies taken on day two and following the supplementation period showed that the majority of 
Cr is absorbed in the first two days.  During the supplemental period, five subjects performed leg 
extension exercises of one of their legs and Cr concentration differences were measured between 
the exercised limb and the non-exercised limb.  Results of the exercise groups showed an 
increase in Cr content in the exercised limb compared to the non-exercised limb. In conclusion, 
Cr supplementation of 25 grams or more successfully loads the muscle with Cr; this can further 
be enhanced with exercise. The majority of Cr absorption takes place in the first two days and 
then continues until the muscle is fully saturated.  The authors suggest that with an increase in Cr 
stores within the muscle could possibly have an impact on sports performance, as an increase in 
Cr would lead to an increase in work capacity. This the first study to address Cr supplementation 
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and thus started the research into Cr as an ergogenic aid. This study has been referred to as the 
fundamental study in Cr research. 
Hultman E, Soderlund, K, Timmons JA, Cederblad G and Greenhaff PL. (1996) 
The purpose of this study was to determine whether muscle Cr stores could be effectively 
increased with different amounts of Cr supplementation and whether elevated levels could be 
maintained with continued low dose Cr supplementation.  Thirty one males where randomly 
allocated into four groups: group one consisted of six participants who consumed 20 grams of Cr 
monohydrate for six days; group two consisted of nine participants who consumed 20 grams of 
Cr monohydrate for six days then two grams a day for the next 28 days; group three consisted of 
nine participants who consumed three grams of Cr for 28 days; and group four consisted of seven 
participants who consumed 20 grams of a placebo for five days.  Muscle biopsies of the vastus 
lateralis were taken for all groups at pre testing and at day seven, 21 and 35 of the supplement 
program to determine Cr concentration levels.  Urine was collected on days one, three, five, 
eight, 11, 18, 22, and 25.  As a result of the muscle biopsies, Cr supplementation of 20 grams for 
six days significantly increases total Cr concentration muscle (P<0.05, Group 1 & 2).  Group one 
exhibited a decline in Cr levels following cessation (day 6) of Cr supplementation while group 
two displayed plateau effect in elevated Cr levels following the loading period with the lesser 
amount of Cr for remaining 28 days.  Group three Cr levels did not significantly increase from 
baseline until day 14 (P<0.001) of Cr supplementation.  Group four did not experience an 
increase in Cr levels during any time point.  The results of the urine analysis indicated that 
urinary creatinine peaks at five days of supplementation (P<0.05).   The authors concluded that 
with the typical loading period, Cr will saturate the muscle in five days and can be maintained by 
a lesser amount (~2 g) of Cr for the duration of supplementation.  The authors also discovered 
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that lower amount of Cr (~3g) can increase Cr concentration, but takes longer to saturate the 
muscle with Cr.  This study was fundamental in addressing the implication of a maintenance 
dose of Cr and the use of a lesser amount of Cr to saturate muscle.  
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CHAPTER III 
METHODS 
Participants 
Forty healthy young men (age: 20.3 ± 1.9 years, Stature: 176.5 ± 6.4, mass 72.4 ± 6.6 kg) 
were recruited for this investigation. All participants completed an informed consent document 
and a health history questionnaire prior to any testing.  To be eligible for inclusion into the study 
all participants met the following requirements: free of any current or ongoing neuromuscular 
diseases, having not sustained a lower limb injury within the last six months,  body contained no 
ferromagnetic implanted material (i.e. pacemakers and metal implants), and have not 
supplemented with Cr within the last six months. Recreationally active subjects where recruited 
and self-reported actively levels where taken (Table 5). Observed power with a sample size of 40 
(n=20 in each group) for the dependent variables ranged from 0.761-0.998, with an effect size of 
0.10-.18. 
Experimental Design 
A randomized, matched-pair, double-blind, placebo controlled design was be used to 
determine the time course effects of Cr supplementation on muscle function. A matched pair 
design was selected per the recommendations of Atkinson et al. 
4
,  participants were matched by 
strength following the familiarization trial and then randomly assigned to the placebo (n=20) or 
Cr (n=20) group.  Participants visited the laboratory on seven occasions (including the 
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familiarization day).  The experimental trials began 2-5 days after the familiarization trial and 
occur at the same time of day (± 2 hrs).  Testing was conducted prior to supplementation, during 
the loading period (2, 4 and 6 days following supplementation) and during the washout period 
(15 and 35 days post supplementation).  A five week washout period was chosen based on the 
findings of Rawson et al. 
88
 who indicated that the time period for muscle Cr levels to return to 
baseline may be longer than the traditional 28 – 30 day period.  During each experimental trial, 
the participants had their body fluid distribution (ICW, ECW and TBW), the size and 
architecture of their medial and lateral gastrocnemius, and tibialis anterior, measured. They also 
underwent passive and active range of motion (ROM) assessments, performed the twitch 
interpolation procedure and isokinetic strength testing.  A randomly assigned subset of 
participants (n=8) underwent proton magnetic resonance spectroscopy (MRS) to detect changes 
in total creatine levels within the muscle during supplementation.
71
  All tests were conducted on 
the right leg.  
Familiarization Day 
During the familiarization trial, each participant completed a health history questionnaire 
and signed an informed consent, practiced the twitch interpolation procedure, isokinetic and 
isometric strength testing and ROM assessments and were informed of the ultrasound and proton 
MRS assessments.     
Supplementation Procedure 
Creatine monohydrate (20g) or a placebo was given to the participants. The creatine and 
placebo was supplied by Dymatize® nutrition and independently tested for quality from Covance 
Laboratories Inc (Madison, WI). The placebo (20g dextrose, 410mg Lemonade flavor, 450mg 
 37 
 
citric acid, 500mg Malic acid, 25mg Sucralose) and Cr  (same as placebo with 5g creatine 
monohydrate added) products were supplied in identical white packets and the participants were 
asked to mix each packet with eight ounces of water and ingest four times throughout the day for 
five consecutive days. Subjects were asked to bring in any unused packets in which no packets 
where returned.  
Body Fluid Distribution  
Total body water (TBW), intracellular water (ICW) and extracellular water (ECW) levels 
were determined using bioimpedance spectroscopy (BIS) (Impedimed SFB7, San Diego, CA). 
Participants lied supine on a table with their legs separated and arms approximately 30 degrees 
from their torso for a 5 – 10 min rest period to ensure the measurements accurately reflect fluid 
distribution (corrects for fluid accumulating in the limb when standing).  Electrodes were placed 
in a tetra-polar configuration using the right foot and right hand to measure total body resistance, 
this  technique has been shown to be both valid and reliable.
75
 Fluid distribution (TBW, ICW, 
and ECW) was calculated using the equations by Deurenberg et al
19
 
TBW (L) = (height
2
 / Z100 x 0.34573) + (weight x 0.17065) - (age x 0.11) + 9.35 
ECW (L) = (height
2
 / Z1 x 0.19528) + (weight x 0.06987) - (age x 0.02) + 2.3 
ICW= TBW-ECW
115
 
From the BIS measurement fat free mass (FFM) and fat mass (FM) were also recorded.  
To account for changes in hydration, urine specific gravity was measured from a urine 
sample collected on each visit. Specific gravity was measured using a clinical handheld 
refractometer (Model 1.33Ade Advanced Optics, Oregon city, OR).  
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Muscle Size and Architecture Measurements 
Muscle cross-sectional area (CSA) was determined by ultrasonography with a 12 Mhz 
linear array probe (LOGIQ e, General Electric Company, Fairfield CT) placed along the axial 
plane at approximately 1/3 the distance between the popliteal crease and the lateral malleolus.  
Images were collected up to a depth of 3.5 cm using the musculoskeletal setting at a frequency of 
10 MHz and a gain of 68 dB.  To avoid a diagonal measurement and an overestimation of muscle 
size, probe position was closely monitored to ensure appropriate skin pressure and the angle of 
the probe by moving the probe against a high density foam pad in the transverse plan.  To 
determine muscle CSA, the medial (MG) and lateral gastrocnemius (LG) and the tibialis anterior 
(TA) were scanned using panoramic ultrasound B mode imaging. For measurements of fascicle 
length (FL) and pennation angle (PA), the angle of the transducer was adjusted visually to 
optimize the muscle fascicles and the intramuscular tendon contained within the field of view.
47
  
Fascicle length and PA of the MG, and LG were measured using panoramic ultrasound B mode 
imaging, with probe displacement being controlled for by maintaining that the center of the 
image was at the same location as the CSA measurement.  All images were digitized and 
evaluated using Image J 1.37 software (National Institutes of Health, Bethesda, MD).  Muscle 
CSA was calculated as the area of the manually traced outline of the muscle just inside the 
surrounding fascia using the polygon function in Image-J.  Using the segmented-line function, 
fascicles will be traced continuously from their origin (deep aponeurosis) to insertion (superficial 
aponeurosis) just inside the surrounding fascia of the MG, & LG.  Pennation angle was measured 
using the angle tool and defined as the angle between muscle fascicle and the deep aponeurosis.  
Two fascicles were measured per muscle and the average FL and PA were used for subsequent 
analysis.
69
 
 39 
 
Electromyography 
Surface electromyography (EMG) was used to monitor muscle activity during the ROM, 
twitch-interpolation and isokinetic strength assessments. Pre-gelled bipolar surface electrodes 
(EL503,Biopac systems inc., Goleta, CA, USA) with an inter-electrode distance of 25 mm were 
be placed on the prominent bulge of MG, and Sol in accordance with the SENIAM guidelines.
46
 
A disposable electrode was placed over the tibial tuberosity to serve as a reference electrode. To 
reduce inter impedance and improve the signal to noise ratio, the skin was shaved, abraded and 
cleaned with isopropyl alcohol prior to electrode placement. Inter-electrode impedance was kept 
below 5 kΩ as measured by a multimeter.  
Range of Motion and Stiffness Assessment 
 The passive ROM of the plantar flexors was determined for each participant on every 
testing day using a Humac Norm dynamometer (CSMI Medical Solution, Stoughton MA) 
programmed in the passive mode.  Participants were seated with the leg extended and restraining 
straps over the pelvis, shoulders, and contralateral thigh and the lateral malleolus aligned with 
the axis of rotation of the dynamometer.  The foot was secured to a foot plate through a thick 
rubber heel cup and straps over the toes and metatarsals (distal to the malleoli so that they did not 
impede any passive foot movement). To examine changes in position, a 150 mm twin axis 
goniometer (BIOPAC Systems, INC., Santa Barbara, CA, USA) was adhered to the skin just 
proximal to the lateral malleolus on the distal aspect of the fibula and on the fifth metatarsal of 
the lateral aspect of the foot.  The dynamometer lever arm was passively dorsiflexed the foot at 
an angular velocity of 5°·sec
-1
 until the participants maximum tolerable ROM was reached then 
immediately returned to -20° of plantar flexion.  Active ROM was assessed as the maximal 
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amount of dorsiflexion the participant can achieve by actively contracting their dorsiflexors.  
Maximal passive and active ROM was calculated as the ROM attained from 0° to the end ROM.   
Passive stiffness was quantified using a fourth-order polynomial regression model 
thatwas fit to the gravity corrected passive angle-torque curves generated during the  passive 
ROM assessment according to the procedures described by Nordez et al.
80
  Passive stiffness 
values (Nm·deg
-1
) were determined at 10° dorsiflexion (common stiffness), and at 80% of 
maximum ROM (relative stiffness).  EMG onset was determined as the point at which EMG 
amplitude of the MG or Sol exceeds three times the baseline EMG standard deviation for longer 
than 100 ms.
10
  Blazevich et al
10
  suggested the onset of EMG activity may indicate an 
appendicular tonic stretch reflex feedback mechanism which may be altered during 
supplementation.
92
  
Isokinetic Testing 
 Isokinetic peak torque (PT) was determined during three consecutive maximal isokinetic 
muscle actions through a spectrum of velocities (30, 90, & 180°·sec
-1
).
29
   Velocities were 
randomized and a two minute rest period was given between tests. The footplate was passively 
moved into dorsiflexion at a velocity at 60°·sec-1 until a verbal cue was given by the participant 
at the point of which the participant felt a slight stretch. The participants then immediately 
performed a rapid and forceful contraction of their plantar flexors until they reached 20⁰ of 
plantar flexion.  Peak torque during isokinetic contractions was measured during the load range 
(zero acceleration)
14
 that occurs at ±10º of neutral (0º).
68
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Twitch Interpolation Procedure 
Isometric peak torque (PT), percent voluntary activation (%VA), and peak rate of torque 
development (RTDpeak), each participant performed three 5-s isometric maximal voluntary 
contractions (MVCs) of the plantar flexors at a neutral joint angle (90º)  with two min of rest 
between trials.  The participants were instructed to push as hard and fast as possible and strong 
verbal encouragement was provided by the investigators.  To determine %VA, transcutaneous 
electrical stimuli was delivered to the tibial nerve using a high-voltage (maximal voltage= 400 
V) constant-current stimulator (Digitimer DS7AH, Herthfordshire, UK). The stimuli was applied 
via bipolar surface electrodes that were be placed in the popliteal space over the tibial nerve.
15
  
Single stimuli was used to determine the optimal probe location (50 mA) and the maximal 
compound muscle action potential (M-wave) with incremental amperage increases (2 -100 mA).  
Once a plateau in the peak-to-peak M-wave was determined, despite amperage increases, 20% is 
added to the amperage that yielded the highest peak-to-peak M-wave to assure as supramaximal 
stimulus.  Doublets (2 single 1-ms square wave impulses) were administered with the 
supramaximal stimulus intensity during the MVC trials to increase the signal-to-noise ratio and 
minimize the series elastic effects on torque production.
18
  In accordance with the twitch 
interpolation procedure, a supramaximal doublet was administered approximately 500 ms into 
the MVC plateau (superimposed twitch) and then again 3-5 s after the MVC trial at rest 
(potentiated twitch).  %VA is calculated with the equation provided by Allen et al.
2
  
%𝑉𝐴 = [1 − (
𝑆𝑢𝑝𝑒𝑟𝑖𝑚𝑝𝑜𝑠𝑒𝑑 𝑡𝑤𝑖𝑡𝑐ℎ
𝑃𝑜𝑡𝑒𝑛𝑡𝑖𝑎𝑡𝑒𝑑 𝑡𝑤𝑖𝑡𝑐ℎ
)] × 100 
 PT was obtained from the average of the first 500 data points preceding the 
superimposed twitch.  RTDpeak was determined from the highest slope value (torque/time) for 
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any 50ms epoch from the onset of torque production.  Three resting twitches were administered 
prior to MVC testing.  From the resting twitches, peak twitch torque (PTtwitch), peak twitch RTD 
(RTDtwitch), and twitch half relaxation time (HRT) were calculated.  PTtwitch was calculated as the 
highest means of 20 consecutive data points that occurs at the apex of the twitch.  RTDtwitch was 
the highest slope value for any 20 consecutive data points during the resting twitches.  HRT was 
calculated as the time it takes the twitch to relax to 50% of its PT.  
Proton Magnetic Resonance Spectroscopy  
A randomly selected subset of 8 participants underwent proton magnetic resonance 
spectroscopy (MRS) scans to determine the changes in total Cr levels in the muscle during 
loading and the subsequent washout period.  All proton MRS scans were performed on a 3T MR 
system (Magnetom Trio, Siemens Healthcare) using a flexible phased array limb matrix coil. All 
MR imaging and proton MRS sequences that were used in this study are FDA approved.  MRS 
consisted of localizer axial, sagittal and coronal images followed by an axial fat-suppressed fast 
spin-echo T2 weighted sequence (TR/TE, 2886/100 msec; field of view 200 mm, 5 mm slice 
thickness) of the gastrocnemius of each participant which were used for MRS voxel placement. 
A single voxel (40 x 40 x 40 mm
3
) was positioned so that the voxel was located entirely within 
the muscle.  Adjacent subcutaneous and intermuscular fat along with boney structures were 
excluded as much as possible. 
Proton MRS scans were performed using a point resolved single volume sequence (SV-
PRESS).  For the measurement of Cr, the SV-PRESS sequence (TR/TE,2000/135) was applied 
twice over the medial aspect of the lower leg (same placement as ultrasound measurements), 
once with water suppression (128 averages)  and once without water suppression (16 averages). 
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Automatic field shimming and manual shimming were used to obtain a full-width and half-
height of less than 0.1 ppm of the water peak will be performed to optimize the signal intensity. 
The scanning times ran less than four minutes for the water-suppressed scan and less than one 
minute for the scan obtained without water suppression. 
Signal Processing 
 The EMG, torque, and position signals were recorded simultaneously with a Biopac data 
acquisition system (MP150WSW, Biopac Systems, Inc., Santa Barbara, CA). The torque (Nm) 
and velocity (°·sec
-1
) signals from the isokinetic dynamometer, position signal from the 
electrogoniometer (°), and EMG (μV) signals were sampled at 2 KHz.  All digitized signals were 
stored on a personal computer (Think Pad T420, Lenovo, Morrisville, NC) and processed off-
line with custom-written software (LabVIEW 8.5).  For the ROM assessments: torque, position 
and velocity signals were filtered with a low pass (10 Hz) zero-phase shift 4
th
 order Butterworth 
filter.  For the strength assessments: torque, position and velocity signals were filtered with a low 
pass (50 Hz) zero-phase shift 4
th
 order Butterworth filter
16
. The EMG signal were bandpass 
filtered with a zero phase shift 4
th
 order Butterworth filter with cutoff frequencies of 10 – 500 
Hz.  The torque signal was gravity corrected for the weight of the footplate. During the isokinetic 
testing, EMG amplitude was calculated as the root mean square (RMS) of same epoch of peak 
torque and normalized to the maximal M-wave (Mmax) per the recommendations of Maffiulette et 
al
67
  for all isokinetic velocities.  M-waves amplitudes (Mmax) were calculated as the RMS values 
as recommended by Arabadzhiev et al.
3
  
Proton MRS data was analyzed using AMARES
79
 which is an advanced method for 
accurate, robust, and efficient spectral fitting and is part of the MR user interface (jMRUI, The 
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training and mobility researchers of the European Union network programmers).  Spectra were 
processed with a zero-order phase correction based on the water peak.  The peak integral values 
of the creatine signal and the non-suppressed water signal were quantified at 3.0 and 4.7 ppm, 
respectively. The quality of the spectra were visually assessed on the basis of a discrete creatine 
peak at 3.0 ppm (creatine linewidth of 10 Hz), and clear separation between creatine and choline 
peaks with no artifacts. 
Statistical Analyses 
Multiple two-way mixed factorial analysis of variances (ANOVAs) [6 x 2; time (pre, 
days 2, 4, 6, 20, 35) x group (creatine vs. placebo)] were used to analyze the effects of Cr loading 
and the washout period on all body fluid compartments (TBW, ICW, and ECW),  muscle 
architecture (CSA, FL, and PA), isometric strength (PT and RTDpeak), muscle activation (%VA 
and normalized EMG amplitude during all isokinetic velocities), resting twitch variables 
(RTDtwitch, PTtwitch, HRT, Mmax), isokinetic PT at (30, 90,180°·sec
-1
), active and passive ROM, 
passive stiffness values, and EMG onset during the passive ROM assessment.  Bonferroni-
corrected pairwise comparisons were used to address the main effects for time.  The alpha level 
was set at P < 0.05, and all analyses were performed with SPSS version 19.0 (SPSS, Inc., 
Chicago, IL).Reliability for main dependent variables where evaluated using model 2,1 to 
determine intraclass correlation coefficient (ICC), standard error of measurement (SEM) and 
percent SEM (%SEM).  
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CHAPTER IV 
RESULTS 
 
Demographics 
Both groups where similar at day 0 in stature, body mass, age, and activity participation 
(P>0.055; Table 5). For body mass, there was no interaction (P=0.449) and no main effect for 
group (P=0.134), however there was a main effect for time (P=0.004).  Body mass increased at 
day 4 and remained higher for the remainder of the time points when compared to day 0 
(P=0.003) and day 2 (P=0.012) for all participants (Figure 1).  For FFM, there was no interaction 
(P=0.120), main effect for group (P= 0.057), or main effect for time (P=0.648). For FM, there 
was no interaction (P=0.872), main effect for group (P= 0.938), or main effect for time (P=0.68).  
For all dependent variables mean± SD are reported in tables 6 and 7. Test-retest reliability 
statistics for all the main dependent variables are reported in table 8.  
Body Fluid distribution 
For TBW, there was no interaction (P=0.348), main effect for group (P= 0.057), or main 
effect for time (P=0.120) (Figure 2A). For ECW, there was no interaction (P=0.106), and no 
main effect for group (P= 0.106), or time (P=0.423) (Figure 2B).  For ICW, there was no 
interaction (P=0.508), and no main effect for group (P= 0.590), or time (P=0.172). (Figure 2C)  
In addition, there was no interaction (P= 0.128), and no main effect for group (P=0.982), or time 
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(P=0.690) for specific gravity.  Cr supplementation did not influence fluid distribution during 
and following Cr loading and hydration status was consistent for all participants.  
 
Muscle Size and Architecture 
For MG CSA, there was no interaction (P=0.452), and no main effect for group 
(P=0.299), or time (P=0.632) (Figure 3A).  For the LG CSA, there was no interaction (P=0.798), 
and no main effect for group (P=0.540), or time (P=0.682) (Figure 3B). For TA CSA, there was 
no interaction (P=0.327), and no main effect for group (P=0.360), or time (P=0.052) (Figure 
3C). Cr supplementation did not influence muscle CSA during and following Cr loading.  
For MG fascicle length, there was no interaction (P=0.201), and no main effect for group 
(P=0.390), however there was an effect for time (P=0.013).  However, follow up pairwise 
comparisons yielded no significant differences (P>0.075) (Figure 4A).  For LG fascicle length, 
there was no interaction (P=0.356), and no main effect for group (P=0.444), or time (P=0.341). 
(Figure 5B)   For MG pennation angle, there was no interaction (P=0.283), and no main effect 
for group (P=0.266), or time (P=0.114) (Figure 5A).  For LG pennation angle, there was no 
interaction (P=0.846), and no main effect for group (P=0.289), or time (P=0.341) (Figure 5B).  
Cr supplementation did not influence muscle architecture during and following Cr loading.  
 
ROM assessments 
For passive ROM, there was no interaction (P=0.149), and no main effect for group 
(P=0.245), however there was an effect for time (P=0.020) with day 20 having greater ROM 
than day 6 (P=0.014) (Figure 6A).  For EMG onset, there was no interaction (P=0.743), and no 
main effect for group (P=0.522), or time (P=0.224) (Figure 6B).  EMG onset was determined 
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with 32 participants (n=16 for each group) since eight did not exhibit EMG onset during the 
ROM assessment. For active dorsiflexion ROM, there was no interaction (P=0.785), and no main 
effect for group (P=0.0362), however there was an effect for time (P=0.035).  However, follow 
up pairwise comparisons yielded no significant differences (P>0.254) (Figure 6C).  Cr 
supplementation did not influence active or passive ROM during and following Cr loading.  
For common passive stiffness, there was no interaction (P=0.478), and no main effect for 
group (P=0.769), or time (P=0.067) (Figure 7A).   For relative passive stiffness, there was no 
interaction (P=0.462), and no main effect for group (P=0.703), however there was an effect for 
time (P=0.013) with day 20 being stiffer then day 0 (P=0.006) (Figure 7B).  Cr supplementation 
did not influence stiffness during and following Cr loading.  
 
Isokinetic Strength 
For isokinetic PT at 30°·sec
-1
,
 
there was no interaction (P=0.931), and no main effect for 
group (P=0.574), however there was an effect for time (P=0.036).  However, follow up pairwise 
comparisons yielded no significant differences (P>0.078) (Figure 8A).  For isokinetic PT at 
90°·sec
-1
, there was no interaction (P=0.971), and no main effect for group (P=0.941), however 
there was a main effect for time (P<0.001) with day 20 having higher values of torque then day 0 
(P=0.001) (Figure 8B).   For isokinetic PT at 120°·sec
-1
,
 
there was no interaction (P=0.967), and 
no main effect for group (P=0.629), however there was a main effect for time (P<0.001) with 
day 20 and 35 having higher PT values then baseline (P=0.001) (Figure 8C).  Cr 
supplementation did not influence isokinetic strength during and following Cr loading.  
For the MG EMG amplitude during the isokinetic test at 30°·sec
-1
,
 
there was no 
interaction (P=0.572), and no main effect for group (P=0.284), however there was an effect for 
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time (P=0.002), with day 35 being more active then day 20 (P=0.030) (Figure 9A).   For the MG 
EMG amplitude during the isokinetic test at 90°·sec
-1
,
 
there was no interaction (P=0.987), and no 
main effect for group (P=0.927), or time (P=0.556) (Figure 9B).   For the MG EMG amplitude 
during the isokinetic test at 120°·sec
-1
,
 
there was no interaction (P=0.133), and no main effect for 
group (P=0.268), or time (P=0.383) (Figure 9C).  Cr supplementation did not influence 
isokinetic MG activation during and following Cr loading. 
For Sol EMG amplitude during the isokinetic test at 30°·sec
-1
,
 
there was no interaction 
(P=0.785), and no main effect for group (P=0.726), however there was an effect for time (P= 
0.001).  However, follow up pairwise comparisons yielded no significant differences (P> 0.128) 
(Figure 10A).   For Sol EMG amplitude during the isokinetic test at 90°·sec
-1
, there was no 
interaction (P=0.939), and no main effect for group (P=0.848), or time (P=0.186)  (Figure 10B).   
For Sol EMG amplitude during the isokinetic test at 120°·sec
-1
,
 
there was no interaction 
(P=0.307), and no main effect for group (P=0.346), or time (P=0.639) (Figure 10C).  Cr 
supplementation did not influence isokinetic Sol muscle activation during and following Cr 
loading.   
 
Isometric MVC PT and %VA  
For maximal isometric MVC PT, there was no interaction (P=0.364), and no main effect 
for group (P=0.708), however there was an effect for time (P=0.001) with baseline being 
stronger then at day 35 (P=0.001) (Figure 11A).  For the RTD, there was no interaction 
(P=0.995), and no main effect for group (P=0.989), or time (P=0.459). (Figure 11B)  For % VA 
there was no interaction (P=0.099), main effect for group (P=0.286), however there was an 
effect for time (P<0.001), with days 20 and 35 being less active then days 0-6 (P=0.001-0.015) 
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(Figure 11B).  Cr supplementation did not influence maximal or explosive isometric strength and 
%VA during and following Cr loading.  
For MG EMG amplitude during the MVC, there was no interaction (P=0.995), main 
effect for group (P=0.647), or effect for time (P=0.674) (Figure 12A).  For Sol EMG amplitude 
during the MVC, there was no interaction (P=0.192), main effect for group (P=0.364), or time 
(P=0.368) (Figure 12B).  Cr supplementation did not influence EMG amplitude of the MG and 
Sol during and following Cr loading.  
 
Twitch Properties 
For the twitch PT, there was no interaction (P=0.354), and no main effect for group 
(P=0.708), however there was a main effect for time (P<0.001) with day 20 having higher PT 
values then day 0 (P=0.001) (Figure 12A).   For twitch RTD, there was no interaction (P=0.698), 
and no main effect for group (P=0.070), however there was a main effect for time (P=0.011) 
with day 6 having a higher RTD then day 2 (P<0.001) (Figure 12B).   For HRT there was no 
interaction (P=0.889), and no main effect for group (P=0.675), or time (P=0.707) (Figure 12C).  
Cr supplementation did not influence resting twitch properties during and following Cr loading. 
 
MRS 
There was no change in MRS values either between groups (P=0.053) or within groups 
(P=0.305; Table 9). (Note: small sample size n= 8)  
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CHAPTER V 
DISCUSSION 
Muscular Strength 
The results of this study demonstrated that Cr loading does not influence isometric or 
isokinetic strength (Figures 8 & 11). These findings are in agreement with previous research that 
reported no improvement in  isometric
8,40,52,95,98,104
 or isokinetic 
21,55,90
  PT during Cr loading.  
However, two previous studies have reported increases in isometric leg extension strength 
following the loading period. For example, Urbanski et al.
103
 and Medieros et al.
72
  reported a 4.2 
and 6.8% increase in isometric strength , respectively.  The discrepancies between these two 
studies and our findings may be due to differences in muscle size (leg extensors vs. plantar 
flexors). These authors have speculated that larger muscles have a greater demand for Cr
103
, as 
increases in strength were reported in the leg extensors but not grip strength following Cr 
loading.  However, others who have studied both larger
21,55,90,98
 and smaller
39,50,51,100
 muscle 
groups reported that Cr had no effect on isometric strength.   
For isokinetic strength, the results of this study (Figure 8) are in agreement with previous 
literature that have demonstrated Cr loading does not influence isokinetic PT
5,21,55,90
 at slower 
velocities ranging from 15 - 120º•secˉ¹.  Although improvements in isokinetic strength have been 
observed at higher velocities (180 and 240 º•secˉ¹)5, other previous studies at a similar 
velocity
55,90
 (180º•secˉ¹) have reported no significant increases in leg extension PT.  It is possible 
that improvements in plantar flexion isokinetic PT may be seen at higher velocities than those 
tested in the current study.  However, it is important to note that this study was unable to 
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examine higher velocities since the load range could not be achieved with the limited ROM 
(~40º) of the ankle compared to the elbow or knee.  
One of the objectives of this current study was to evaluate the effect of Cr loading on the 
speculated mechanisms that may lead to an increase in strength.  These mechanisms include: (1) 
increases in muscle activation
73
, (2) increases in muscle size or pennation angle
52,102
, and (3) 
improvements in Ca
2+
 kinetics
5
.  All three possible underlying mechanisms were examined in 
this current study during and following Cr loading (Figures 3-5, 9-13).  Similar to the lack of 
interaction effects found for all strength measures, we also found no significant changes 
(P>0.05) when compared to the placebo condition in these variables during and following the Cr 
loading period.  
 For muscle activation, our findings (Figures 9-11) are in agreement with previous 
literature that have reported normalized EMG amplitude values and %VA are not influenced by 
Cr loading
52,53,95
.  There is only one previous study
73
 that has reported  an increase in muscle 
activation following Cr loading. The differences between these results may be contributed to the 
normalization procedures, as the studies that have reported no changes examined normalized 
EMG amplitude 
53,95
 or %VA, while Medeiros et al.
73
 reported raw RMS EMG amplitudes which 
have been reported to be influenced by physiological and non-physiological factors.
25
  Similarly, 
there was no influence of Cr loading on muscle CSA, PA and fascicle length (Figures 3-5). 
These measurements were examined based on the speculation of Jakobi et al.
52
 who stated that 
“it is conceivable that an increase in ICW102 could affect pennation of the muscle fibers which 
might affect over all force output”(pg. 458). To our knowledge, is the current study is the only 
study to examine muscle architecture during and following Cr loading while simultaneously 
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measuring water distribution.  These findings are not surprising given there was no reported 
changes in ICW.  
Lastly, it has been suggested that Cr loading would improve Ca
2+
 kinetics by enhancing 
ATP availability and thus increase the Ca
2+
-ATPase pump and subsequently improve  cycling 
rates
5,104
.  These variables are often examined indirectly through evoked twitch conditions
44
.  
However, our findings indicated that there was no change in evoked twitch properties (PTtwitch, 
RTDtwitch, & HRT) during and following Cr loading (Figure 13). The majority of papers 
examining twitch properties following Cr loading have reported no improvements in PTtwitch, 
RTDtwitch, HRT, and time to PT
52,53,95
.  However, there is one previous study
5
 that has reported an 
increase in PTtwitch which may be due to the stimulation procedure utilized.  For example, 
Bazzuchi et al.
5
 used a train of stimuli (10 single impulses for 469 μs) compared to single square 
wave impulses (50-200 μs) that are commonly used in the literature52,53,95.  
Range of Motion 
We are aware of only one study that has examined the influence of Cr supplementation 
on flexibility.  Sculthrope et al.
92
 examined the influence of Cr loading on a number of upper and 
lower body active ROM assessments and reported a decrease in shoulder extension (~9º)  and 
flexion (~9º),  as well as dorsiflexion (~2º). They speculated that the Cr induced increase in 
muscle cell volume (i.e. increase in ICW) would either result in an increase in the resistance to 
stretch thereby increasing overall muscle stiffness, or influence neural outflow from the muscle 
spindles causing them to be activated earlier in a given ROM.  The results of our study 
demonstrated that both active and passive ROM (Figure 7) were not altered during and following 
Cr supplementation.  In addition, we found there was no change in ICW (Figure 2), passive 
stiffness at a common and relative joint angles (Figure 8) or EMG onset (Figure 7) which may 
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indicate muscle spindle activity was not altered.  Furthermore, Watsford et al. 111 previously 
examined the influence of Cr loading on active musculotendinous stiffness of the plantar flexors 
and reported that Cr supplementation does not alter stiffness.  Collectively, these findings may 
suggest that Cr loading has little influence on altering the passive resistive characteristics of the 
plantar flexor muscles.    
Body Mass 
It has often been reported that Cr supplementation increases body mass in men ranging 
from (1-3 kg)
61,97,107
 following a traditional loading period. It is believed that the increase in 
body mass is a result of the osmotic load caused by Cr retention in the muscle
102
.  Our findings 
indicated that there were no significant changes in body mass when compared to the placebo 
condition (Figure 1). The Cr group demonstrated changes of (1.1±1.1 kg) following the 5 day 
loading period which is within the range of commonly reported gains in body mass
62
.   While Cr 
supplementation has been examined extensively
97
, very few studies examine changes in muscle 
Cr stores to verify and often indirectly use changes in body mass to support these changes.  
Using a subset of participants (n=8) from this study, we examined total muscle Cr content with 
MRS technology
88
.  It is apparent that muscle Cr stores increased during the loading period and 
declined through day 20 and 35, but where remained above day 0 values (Figure 14).  The 
placebo group demonstrated no increase in Cr levels from day 0.  These findings may suggest 
that Cr stores increased during the traditional loading period and slowly returned to baseline 35 
days later which are consistent with the findings of Hultman et al.
48
 who showed that Cr levels 
peak after loading and slowly decline after day 35.  
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Conclusion 
Overall, our findings demonstrate that Cr loading alone does not influence neuromuscular 
function.  These finding support the work of previous authors who reported no changes in 
isometric 
8,40,52,95,98,104
 or isokinetic 
21,55,90
 strength following Cr loading. The few studies
5,73,103
 
that have reported improvements in strength have only merely speculated the possible underlying 
mechanisms. Thus, one of the main goals of this study was to address all of these possible 
mechanisms that may lead to an increase in muscle strength with Cr supplementation. Our results 
demonstrate that muscle activation, muscle architecture, and Ca²
+
 kinetics measured indirectly 
through twitch properties remained unchanged during and following Cr loading.  Taking into 
consideration the results of this study and the current body of literature, Cr loading alone has 
little influence on neuromuscular parameters that may improve muscular strength. 
A novel finding of this study was that Cr loading did not influence passive ROM and 
stiffness.  Previous authors have measured active ROM
92
 and stiffness
111
, separately, and 
reported a decrease in ROM and no change in active stiffness using the oscillation technique in 
the plantar flexor muscles. Sculthrope et al.
92
 speculated that an increase in muscle size as a 
result of Cr loading would increase stiffness and/or muscle spindle activity thereby reducing 
active ROM.  However, our results demonstrated that muscle CSA, passive stiffness and EMG 
onset (an indirect assessment of spindle activity) where not influenced by Cr loading. As a result 
of this study it appears Cr loading does not influence neuromuscular components that influence 
flexibility. Previous research has speculated that non-significant results partially could be 
contributed to “responders” vs “non-responders”59,101.  It is believed that up to 30% of the 
population are “non-responders” which have limited Cr absorption by the muscle as defined as 
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less than 10 mmol·kgˉ¹ dw increase in Cr stores37. Therefore, it is possible that many of our 
participants were “non-responders”, however, this topic is still not well understood and warrants 
more investigation using techniques to examine changes in muscle Cr levels.  
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Table 2: The influence of Cr Supplementation on neuromuscular function cont… 
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Table 3: The influence of Cr supplementation on ROM and stiffness 
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Table 5: Participant demographics and amount of time per week exercising (mean ± SD)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age (yrs) Stature (cm) Mass (Kg) Aerobic  training (hrs) Resistance training  (hrs.)
Placebo (n=20) 20.3±2.1 176.9±6.4 74.1±7.2 2.1±1.8 2.8±2.2
Creatine (n=20) 20.4±2.3 176.1±5.8 70.7±5.6 2.8±1.8 2.1±1.8
6
0
 
  
 
Table 6: Dependent variables (mean± SD) for all days)  
 
Day 0 Day 2 Day 4 Day 6 Day 20 Day 35
Mass (Kg) Pl 74.2 ± 7.2 74.3 ± 7.3 74.4 ± 7.2 74.3 ± 7.1 74.7 ± 8.2 75.1 ± 8.4
Cr 70.6 ± 5.6 70.6 ± 6.1 71.1 ± 5.9 71.5 ± 5.8 71.6 ± 6.1 71.8 ± 6.3
Specific Gravity (kg·mˉ³) Pl 1.0 ± 0.4 1.0 ± 0.6 1.0 ± 0.5 1.0 ± 0.4 1.0 ± 0.5 1.0 ± 0.3
Cr 1.0 ± 0.4 1.0 ± 0.5 1.0 ± 0.4 1.0 ± 0.5 1.0 ± 0.6 1.0 ± 0.5
Fat Free Mass (Kg) Pl 60.6 ± 6.3 60.8 ± 6.4 60.9 ± 5.9 60.9 ± 6.2 59.6 ± 7.9 61.3 ± 7.2
Cr 57.3 ± 5.9 56.5 ± 4.2 58.0 ± 4.4 58.9 ± 5.2 56.5 ± 6.1 57.5 ± 4.1
Fat mass (Kg) Pl 13.3 ± 4.4 13.3 ± 4.9 13.5 ± 5.0 13.7 ± 5.8 14.8 ± 6.1 15.0 ± 5.6
Cr 13.6 ± 5.3 14.0 ± 4.3 13.0 ± 5.2 13.3 ± 5.0 14.5 ± 6.1 14.4 ± 4.2
Total Body Water (L) Pl 44.3 ± 4.6 44.5 ± 4.7 44.6 ± 4.3 44.6 ± 4.6 43.7 ± 5.8 44.8 ± 5.3
Cr 42.0 ± 4.3 41.4 ± 3.1 42.5 ± 3.3 43.1 ± 3.8 41.3 ± 4.5 42.1 ± 3.0
Extracellular Water (L) Pl 18.3 ± 1.6 18.2 ± 1.9 18.2 ± 1.6 18.3 ± 1.7 17.6 ± 3.0 18.5 ± 2.2
Cr 17.2 ± 1.5 17.0 ± 1.4 17.5 ± 1.5 17.8 ± 1.6 17.5 ± 1.5 17.3 ± 1.4
Intracellular Water (L) Pl 26.0 ± 3.5 26.4 ± 3.0 26.5 ± 2.9 26.3 ± 3.1 26.0 ± 3.3 61.3 ± 7.2
Cr 24.8 ± 3.1 24.3 ± 2.0 25.0 ± 2.1 25.4 ± 2.5 23.8 ± 4.1 24.8 ± 4.1
MG CSA (cm²) Pl 13.8 ± 3.3 13.3 ± 3.5 13.3 ± 2.9 14.0 ± 3.2 13.8 ± 3.7 13.3 ± 3.7
Cr 12.3 ± 1.9 12.6 ± 2.7 12.9 ± 3.0 12.8 ± 3.0 12.8 ± 2.4 12.7 ± 3.0
LG CSA (cm²) Pl 5.8 ± 1.8 6.0 ± 1.8 5.7 ± 1.8 5.9 ± 1.9 5.7 ± 1.9 5.8 ± 1.9
Cr 5.9 ± 1.7 6.3 ± 2.0 6.3 ± 1.9 6.3 ± 1.8 6.2 ± 2.0 6.0 ± 2.2
TA CSA (cm²) Pl 4.0 ± 0.9 4.1 ± 0.9 4.1 ± 0.9 4.2 ± 1.0 4.0 ± 0.9 4.2 ± 0.9
Cr 4.2 ± 1.0 4.2 ± 0.9 4.2 ± 0.9 4.3 ± 0.8 4.4 ± 1.1 4.6 ± 1.0
Fascicle length MG (mm) Pl 5.8 ± 0.9 6.0 ± 0.9 5.8 ± 0.7 6.0 ± 1.1 5.7 ± 0.8 5.9 ± 0.9
Cr 5.3 ± 0.7 5.8 ± 0.7 5.5 ± 0.7 5.9 ± 1.1 5.8 ± 0.8 5.7 ± 0.8
Fascicle length MG (mm) Pl 5.8 ± 0.7 5.8 ± 0.8 5.8 ± 0.6 5.9 ± 1.0 5.6 ± 0.8 5.8 ± 0.5
Cr 5.3 ± 0.8 5.8 ± 0.9 5.5 ± 0.8 5.9 ± 1.2 5.6 ± 0.9 5.6 ± 1.0
Pennation angle MG (º) Pl 19.8 ± 3.8 18.3 ± 3.7 20.3 ± 3.6 19.6 ± 4.2 21.5 ± 4.6 18.9 ± 3.2
Cr 21.0 ± 3.5 19.5 ± 3.7 21.1 ± 3.6 20.7 ± 3.4 19.7 ± 3.6 20.6 ± 3.6
Pennation angle LG (º) Pl 15.2 ± 3.4 15.5 ± 4.9 15.1 ± 3.6 14.9 ± 3.3 15.6 ± 3.0 15.0 ± 2.2
Cr 15.6 ± 4.1 16.5 ± 4.2 16.2 ± 3.9 16.2 ± 4.3 17.0 ± 2.9 14.9 ± 3.4
Passive ROM (º) Pl 18.1 ± 1.1 17.0 ± 1.0 16.7 ± 0.9 19.3 ± 1.6 20.6 ± 1.5* 22.5 ± 1.2
Cr 20.0 ± 0.2 20.3 ± 0.2 21.3 ± 0.2 19.3 ± 0.2 24.3 ± 0.2 20.7 ± 0.2
Active ROM (º) Pl 10.1 ± 4.8 9.2 ± 5.4 8.8 ± 5.2 8.3 ± 4.6 8.2 ± 4.4 8.6 ± 4.7
Cr 13.7 ± 6.1 11.5 ± 4.9 12.1 ± 7.0 12.2 ± 7.4 10.7 ± 7.8 10.7 ± 6.1
EMG onset (º) Pl 11.9 ± 1.1 7.7 ± 0.6 9.2 ± 0.6 9.6 ± 0.7 10.8 ± 0.9 10.4 ± 1.1
Cr 11.2 ± 1.2 9.3 ± 0.9 8.4 ± 0.7 10.5 ± 1.1 14.4 ± 2.0 11.6 ± 1.3
Realtive Stiffness (Nm·ºˉ¹) Pl 6.0 ± 2.3 6.8 ± 3.2 6.8 ± 3.6 7.4 ± 2.8 6.9 ± 2.6# 7.6 ± 3.1
Cr 5.8 ± 3.1 6.3 ± 3.3 5.8 ± 2.7 7.0 ± 2.9 8.1 ± 2.6 7.2 ± 2.2
Common Stiffness (Nm·ºˉ¹) Pl 5.2 ± 3.2 6.8 ± 4.2 6.7 ± 4.6 5.9 ± 4.0 7.6 ± 4.2 7.9 ± 3.6
Cr 5.8 ± 2.9 5.6 ± 3.2 5.9 ± 4.0 7.2 ± 4.4 7.3 ± 3.9 6.9 ± 4.4
Pl placebo, Cr Creatine,  MG medial gastrocnemius, LG lateral gastrocnemius, TA tibialis anterior, CSA cross sectional area,  EMG electromyography, ROM range of 
motion  *P≤0.05, significant difference in PT with day 20 > day 6 for both groups, # P≤0.05, significant difference in relative stiffness with day 20 > day 6
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Table 7: Dependent variables (mean± SD) for all days cont…. 
  
 
 
Day 0 Day 2 Day 4 Day 6 Day 20 Day 35
Isokinetic PT 30ºsec·ˉ¹ (Nm) Pl 112.4 ± 29.2 119.7 ± 20.5 119.3 ± 27.8 114.8 ± 20.5 120.5 ± 19.2 123.1 ± 22.2
Cr 111.5 ± 23.6 112.9 ± 30.9 113.0 ± 21.0 112.0 ± 24.5 118.3 ± 23.0 121.3 ± 21.8
Normalized EMG MG IK 30ºsec·ˉ¹ (%) Pl 0.6 ± 0.4 0.6 ± 0.4 0.9 ± 0.9 1.0 ± 0.9 0.6 ± 0.5 1.1 ± 1.1
Cr 0.9 ± 0.8 0.9 ± 0.8 1.0 ± 0.8 0.9 ± 0.6 0.8 ± 0.7 1.5 ± 1.5
Normalized EMG Sol IK 30ºsec·ˉ¹ (%) Pl 2.4 ± 1.8 2.6 ± 2.1 2.2 ± 3.3 2.2 ± 2.4 2.7 ± 2.0 1.9 ± 1.7
Cr 2.6 ± 2.7 3.2 ± 3.2 2.2 ± 2.3 2.1 ± 2.0 2.8 ± 1.7 3.0 ± 3.3
Isokinetic PT 90ºsec·ˉ¹ (Nm) Pl 66.3 ± 17.8 72.0 ± 13.8 71.5 ± 19.4 71.4 ± 16.2 75.6 ± 11.1* 80.7 ± 15.9
Cr 69.0 ± 18.1 70.1 ± 19.9 70.1 ± 14.9 70.4 ± 18.0 75.4 ± 19.4 80.7 ± 12.5
Normalized EMG MG IK 90ºsec·ˉ¹ (%) Pl 1.2 ± 2.9 1.2 ± 2.9 1.0 ± 0.9 1.1 ± 1.0 0.7 ± 0.5 1.2 ± 1.1
Cr 1.1 ± 1.3 1.1 ± 1.3 1.1 ± 0.9 1.1 ± 0.8 0.9 ± 0.8 1.4 ± 1.4
Normalized EMG Sol IK 90ºsec·ˉ¹ (%) Pl 1.5 ± 1.2 1.4 ± 1.2 1.2 ± 2.0 1.2 ± 1.7 2.2 ± 3.8 1.2 ± 1.3
Cr 1.7 ± 1.7 1.4 ± 1.3 1.1 ± 0.9 1.3 ± 1.5 2.0 ± 1.9 1.7 ± 2.5
Isokinetic PT 120ºsec·ˉ¹ (Nm) Pl 53.6 ± 17.2 56.8 ± 17.5 57.3 ± 17.0 56.5 ± 13.1 68.6 ± 9.8 64.3 ± 11.7
Cr 58.2 ± 12.5 58.1 ± 17.6 57.9 ± 16.6 59.2 ± 20.0 69.5 ± 14.2 65.1 ± 15.9
Normalized EMG MG IK 120ºsec·ˉ¹ (%) Pl 1.3 ± 1.0 0.7 ± 0.6 1.0 ± 1.1 1.1 ± 1.0 0.8 ± 0.7 1.2 ± 1.5
Cr 1.2 ± 1.1 1.4 ± 1.7 1.1 ± 1.0 1.0 ± 0.6 0.9 ± 0.7 1.4 ± 1.5
Normalized EMG Sol IK 120ºsec·ˉ¹ (%) Pl 1.3 ± 1.1 1.0 ± 0.9 0.7 ± 0.9 1.3 ± 2.0 1.6 ± 1.9 1.1 ± 1.8
Cr 1.4 ± 1.7 1.4 ± 1.1 1.4 ± 1.3 1.2 ± 1.5 1.6 ± 1.7 1.6 ± 2.1
Isometric  PT (Nm) Pl 119.3 ± 26.1 114.7 ± 26.9 111.3 ± 27.1 107.4 ± 25.3 111.2 ± 30.3 95.9 ± 21.1
Cr 116.2 ± 28.0 109.1 ± 34.1 101.1 ± 42.3 105.6 ± 28.3 106.5 ± 32.3 103.8 ± 27.8
% VA (%) Pl 89.8 ± 10.8 90.0 ± 12.1 85.3 ± 14.3 88.4 ± 12.8 83.7 ± 16.2# 74.7 ± 16.3#
Cr 95.4 ± 5.6 90.2 ± 12.1 92.1 ± 15.1 87.1 ± 14.2 84.7 ± 17.4 83.5 ± 14.5
RTD (Nm·sˉ¹) Pl 609.6 ± 179.2 616.7 ± 161.0 560.5 ± 156.2 552.3 ± 123.6 577.7 ± 153.7 623.1 ± 227.4
Cr 604.0 ± 183.0 605.6 ± 303.0 569.8 ± 138.5 570.1 ± 217.3 589.8 ± 211.1 605.5 ± 205.7
Normalized MG EMG (%) Pl 1.3 ± 1.0 1.3 ± 1.0 1.4 ± 2.0 1.2 ± 1.8 1.3 ± 1.2 1.1 ± 1.4
Cr 1.2 ± 1.1 1.2 ± 1.1 1.2 ± 1.0 1.1 ± 0.9 1.3 ± 0.9 0.9 ± 0.8
Normalized Sol EMG (%) Pl 0.9 ± 0.5 0.9 ± 0.4 0.8 ± 0.6 1.1 ± 0.8 1.2 ± 1.0 0.7 ± 0.6
Cr 1.2 ± 0.8 1.2 ± 0.8 1.1 ± 0.7 0.9 ± 0.6 1.2 ± 1.0 0.9 ± 0.8
Twitch PT (Nm) Pl 22.4 ± 6.8 22.4 ± 6.8 23.9 ± 6.6 24.9 ± 6.1 27.3 ± 6.6 26.2 ± 6.8
Cr 19.5 ± 6.4 19.6 ± 6.4 21.0 ± 5.8 22.5 ± 6.0 24.5 ± 5.7 25.3 ± 6.1
Twitch RTD (Nm·sˉ¹) Pl 575.9 ± 188.8 575.9 ± 188.8 584.8 ± 206.9 641.4 ± 160.7 693.5 ± 160.1 667.4 ± 198.0
Cr 481.0 ± 175.5 481.0 ± 175.5 507.0 ± 192.4 584.3 ± 150.5 652.8 ± 177.4 646.2 ± 168.0
HRT (sec) Pl 83.9 ± 14.6 84.1 ± 14.5 90.2 ± 32.2 92.9 ± 41.7 88.3 ± 29.2 87.1 ± 31.6
Cr 86.5 ± 12.7 86.5 ± 12.7 83.4 ± 27.1 90.2 ± 22.2 89.2 ± 26.5 80.5 ± 10.3
Pl placebo, Cr Creatine, PT peak torque,IK isokinetic,  MG medial gastrocnemius, Sol soleus, EMG electromyography, RTD rate of torque development                 
*P≤0.05, significant difference in PT with day 20 > day 0 for both groups, # P≤0.05, significant difference in % VA with day 20 and 35 > day 0-6
6
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Table 8: Reliability statistics for the main dependent variables 
 
 
 
ICC2,1 SEM %SEM P value
Isometric  PT 0.90 7.06 5.93 0.16
Isokinetic PT 30ºsec·ˉ¹ 0.78 15.13 13.51 0.93
Isokinetic PT 90ºsec·ˉ¹ 0.78 7.6 9.50 0.74
Isokinetic PT 120ºsec·ˉ¹ 0.81 9.03 13.28 0.82
Passive ROM (º) 0.84 3.27 18.17 0.78
Active ROM (º) 0.88 1.99 16.58 0.09
Common Stiffness 0.88 1.61 20.38 0.34
% VA 0.83 5.98 6.64 0.71
CSA MG 0.88 1.57 11.38 0.33
Pennation angle MG 0.84 1.92 8.93 0.35
Fascicle length MG 0.76 0.627 10.63 0.46
Total Body Water 0.98 0.99 2.21 0.94
Intracellular Water 0.95 0.87 3.23 0.25
Extracellular Water 0.92 0.66 3.57 0.49
Twitch PT 0.87 3.03 11.10 0.08
HRT 0.94 7.2 7.75 0.06
PT peak torque, CSA crosssection area,  ROM range of motion, MG 
medial gastrocnemius, HRT half relxation time 
6
3
 
  
 
Table 9: Muscle creatine concentration determined by magnetic resonance spectroscopy (mean ± SD) 
 
Day 0 Day 2 Day 4 Day 6 Day 20 Day 35
Placebo 67.6± 14.0 (mmols) 64.2± 10.9 64.9± 10.9 60.4± 13.6 56.8.± 9 .1 58.2± 11.8
Creatine 68.9± 11.2 87.6± 18.6 72.6± 11.8 76.6± 10.0 73.5± 9.8 73.3± 3.9
6
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